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Abstract 
Background: Glaucoma is the second leading cause of blindness worldwide. Glaucoma is a group 
of eye diseases that permanently damage visual functions and can impact patient quality of life 
negativity. Quality of Life has emerged as an important parameter for assessing the quality of 
health care of patients with Glaucoma disease. So, the present study was carried out in Al Nasser 
Ophthalmic Hospital and European Gaza Hospital, with the aim to assess and evaluate QOL among 
Glaucoma patients in Gaza Governorates and the factors influencing their life conditions. 
Methods:  This descriptive, analytical, cross-sectional study included 265 glaucoma patients 
whose age was 18 years or more. Data collected at Al Nasser Ophthalmic Hospital and European 
Gaza Hospital included socioeconomics, demographics and disease characteristics. QOL data 
collected using the Glaucoma Quality of Life-15 questionnaire (GQL-15) and Medical Outcomes 
Study Short-Form 36 Health Survey (SF-36) questionnaire. 
Results: The results showed that study participants had a medium perception level of QOL. The 
mean summary score for GQL-15 was 59.2 ± 17.6. Patients showed the greatest difficulty in 
activities involving glare and dark adaptation (48.5 ± 18.0), followed by central and near vision 
(57.3 ± 19.1), peripheral vision (61.4 ± 19.4), and the least difficulty for outdoor mobility (66.6± 
25.4). Moreover, the overall mean percentage of SF-36 domain scores 61.7±13.5. The bodily pain 
domain got the highest score (79.4). Moreover, the social function domain was (72.22), the 
physical function domain (70.32), the emotional role limitation (58.24), the role limitation due to 
physical health (55.75), the mental health domain (54.7), the vitality domain (54.09), and the 
lowest domain was General health with equaled (48.58). 
Finding showed that females had poorer QOL in SF-36 than male (64.5 vs. 58. 2). QOL was better 
at age group (18-30) (66.3), compared with the other participants. Moreover, participants with an 
income of more than 1000 NIS had better QOL. For disease-related variables, finding showed that 
participants without (ocular disease and comorbid) had better QOL compared with those who had 
an ocular disease and comorbid.  
In addition, finding presented that, patients with disease duration less than 5 years had a better 
degree of QOL domains. In addition, findings showed that glaucoma patient's when attended more 
educational represented higher QOL.  
 
Conclusion: The findings demonstrated that patients with Glaucoma disease had a medium level 
perception about their QOL. This study identified common problems encountered by patients 
which now are not assessed in routine glaucoma care. It also identified a subgroup of questions that 
seems to be specific for glaucoma. Also, a study has proved that Glaucoma has wide effects on 
people‘s ability to function independently in every field of their lives. It affects the physical, mental 
and social well-being of people. Glaucoma patients should be educated to understand the prognosis 
of the disease and importance of the adherence to daily treatment. 
 
Recommendations: Results highlight some important recommendations such as: increasing 
efforts to prevent negative impacts of disease on QOL of patients by improving a quality of eye 
care and establishing vision rehabilitation program. Planning and implementing educational 
programs for the optometrist to help Glaucoma Patients to cope better with their chronic disease are 
very crucial Moreover, development of medical patient file at diagnostic units and enhancement of 
proper documentation and stability in the availability of fundamental medications are important 
steps to improve QOL. There is a need to conduct more research studies, including both qualitative 
and quantitative studies to understand individual areas of need which can be addressed in the 
future. 
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Chapter One Introduction 
1.1 Background 
Glaucoma is considered one of the major health problems worldwide with increasing 
incidence and social impact. It's the second-leading cause of blindness globally. In 2013, it 
was estimated that there are 64.3 million people in the world with Primary Open-Angle 
Glaucoma (POAG) and Primary Angle-Closure Glaucoma (PACG). By the year 2020, this 
number is predicted to increase to 76.0 million and the number of people with glaucoma 
worldwide will rise to 111.8 million in 2040 (Tham, 2014). 
Epidemiological studies demonstrate that disease prevalence increasing significantly with 
age. Glaucoma can affect patient‘s quality of life (QOL) in several ways: worsening visual 
function; the mental burden produced by diagnosis, fear of blindness (Janz et al., 2007), 
anxiety and depression (Mabuchi et al. 2008), the possible side effects of treatment 
(medical and/or surgical), and the financial burden (cost of clinic visits and medical 
therapies) (Bramley et al., 2008). Patients with reduced QOL place a greater financial 
burden on healthcare systems and society than those with better QOL. So, maintaining a 
patient‘s QOL has always been an important goal for glaucoma treatments. 
The interest of clinicians and researchers concerning the quality of life assessment in 
chronic disease's increases constantly. A Quality of life is an important indicator of health 
and well-being. It determines the effectiveness of treatment, chooses the main concern for 
resource's distribution, and help in policy improvements (Karen, et al. 2008).  Assessment 
of quality of life is being increasingly established as a critical measurement in monitoring 
and evaluating the effectiveness of different treatments for glaucoma (Janz et al., 2001; 
Nelson, 2003). 
Glaucoma is one of the major causes of blindness in Palestine, and for those not blind, may 
affect QOL in many ways. Here in Gaza strip, there is no reliable published data about the 
prevalence of glaucoma and glaucoma subtypes.  
Furthermore, assessment of the quality of life in glaucoma patients has not been previously 
studied in Gaza strip. The finding and recommendation of this study will be presented to 
the decision makers, to promote alterations and guidelines regarding patients‘ daily living 
and safety and contribution to improving the quality of life in the glaucoma patients. 
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1.2 Research problem 
Loss of vision has a statistically significant association with disability, has broad effects on 
people‘s ability to function independently in every scope of their lives, as indicated by loss 
of personal independence, impaired mobility and falls, depression, transportation 
challenges, difficulties maintaining employment, and placement in long-term care. As 
people‘s vision worsens, their psychological burden increases along with a fear of 
blindness and social withdrawal (Campbell & Crews, 2001; Ramulu et al., 2012; Skalicky 
& Goldberg, 2008).  
Glaucoma is the second most common cause of loss of vision worldwide; it is potentially 
life-threatening and life-limiting condition that causes of distribution in education and 
social activities. Therefore, it is important to focus upon the problem presented by patients 
with Glaucoma, assessing their QOL and related problems, which could be directly 
affecting on their various life domains. 
In the meantime, it's important for evaluation the knowledge and outcome of the patient 
receiving Health Care. This is particularly the case for a patient with a long-term chronic 
disease, since complete cure for their illness is often impossible (Macduff, 2000). 
There is unclear data for patient needs and  Lack of the qualitative and quantitative studies. 
For this reason, the current study takes a place to assess the quality of life for the glaucoma 
patient in GGS in order to contribute in the Improvement of their quality of life. The 
researcher  will study the quality of  life for the glaucoma patient for the first time in 
Palestine. 
1.3 Justification 
Health care professionals thus should give special attention to not only the influence of the 
disease or handicap on the everyday functioning of their patients (that equal health status), 
but also to their patients‘ satisfaction with their physical, psychological, and social 
functioning (that equal QOL) (De Vries, 2001; De Vries and Drent, 2006). 
Glaucoma causes a high burden of disease and disability. In particular, glaucoma impacts 
on an individual‘s visual, social, physical and psychological functioning, and increases the 
risk of a number of adverse health outcomes.  
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QOL needs to be considered when evaluating the knowledge and outcome of patients 
receiving health care because it's an important parameter. This is particularly the case for 
patients with long term chronic diseases (Macduff, 2000). 
Quality of life assessment is very important indicator of outcome of medical service and 
provides understanding of nature of disease and experiences of patients, and work as 
guide of efficiency of treatment. In view to the fact that there is no study conducted the 
quality of life among the glaucoma patient's in our society.  A great attention should be 
directed toward those who are suffering from this threatening and disabling disease 
because those people are in desperate need of healthcare, Rehabilitation follow- up, health 
education, advising and ongoing medical treatment, these efforts based on a realistic study 
and careful assessment of their needs and what fit their abilities to reduce the worry and to 
prepare them to live safe and healthy lifestyles. 
The study will spotlight on QOL among Glaucoma patients in GG in order to evaluate 
QOL domains. In addition, the assessing of QOL among Glaucoma patients may contribute 
to the investigation of the effectiveness and responsiveness of the HCS. 
1.4 Aim of the study 
The aim of this study is to assess and evaluate Quality of Life among glaucoma patients in 
Gaza Governorates, in order to improving their QOL and to provide knowledge about the 
impact of glaucoma on the QOL of those patients. 
1.5 Study objectives 
1- To assess the QOL levels among glaucoma patient in GG. 
2- To identify Glaucoma patients‘ perceptions about their General health 
3- To assess the impact of glaucoma on QOL domains of glaucoma patient. 
4- To determine the relationship between socio demographic factors and QOL. 
5- To explore the relationship between the health profile and QOL of Glaucoma patients 
6- To provide recommendations to improve QOL and enhance activity of daily 
    Life (ADLS) among those patients. 
1.5 Research Questions 
1- Dose the glaucoma patient in Gaza governorates enjoying QOL? 
2- Are Glaucoma patients are satisfied with their health? 
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2- How do the glaucoma patients view their QOL? 
3- What is the impact of glaucoma on QOL? 
4-What are the socio demographic characteristic associated with QOL among  glaucoma 
patient? 
5- What is the relationship between health profile and QOL in Glaucoma patients? 
6-What are the recommendation could be drown from the study in order to enhance      
QOL among glaucoma patient in GGs? 
1.6 Context of the study 
This study is about a quality of life among glaucoma patients at hospitals in the Gaza strip, 
so it will be affected by the geographical area and the socio economic, educational 
situation. However, it is important to show some details about this context as follows: 
1.6.1 Gaza Governorate demographic characteristics  
The Gaza Strip (GS) is a small part of land located in the southern area of Palestine 
(Annex1). According to the Palestinian Central Bureau of Statistics (PCBS)the total number 
of population was 1,850,559 with high population density; more than 5,070 individuals per 
square kilometer (PCBS, 2016). This high population density resulted in high demands for 
health care services and possible work overload for health care providers in this crowded 
area.  
The Gaza strip is divided into five governorates: North Gaza, Gaza City, Mid Zone, 
Khanunis and Rafah (Palestinian Water Authority, 2013) characterized by less wide spaces 
and less remote areas compared with the West Bank; resulting in better geographical 
accessibility for the healthcare services.  
1.6.2 Socio-economic situation  
In the last years, economic situation continued to severely drop in the case of 
implementation of stricter closures on Gaza after the Palestinian legislative election in 
2006 and the Palestinian conflict which lead to gap between the two sides of the 
Palestinian territories, the Gaza Strip and the West Bank. 
The poverty rate in 2008 was expected to be higher than it was in 2006 (Giacaman et. al., 
2009). This worsening in economic situation had its' negative impacts on financial access 
to health care facilities. Furthermore, the terrible attack of Israeli military in December 
2008 and November 2012 and July 2014 in Gaza Strip increase the burden of poverty due 
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to the massive destruction of the public infrastructure and utilities, including water, 
sanitation, electricity, transportation networks, educational institutions and homes. 
Furthermore, the closure of most factories that lacked its' raw material and preventing the 
export of the farmer's crops. Overall, this bad economy affected the amount of 
governmental revenues, which use as a source for the health care system, lead to depend on 
the donation in providing the needed health care services. 
1.6.3 Health context  
Matched to the region, the Palestinian population's overall health status outcomes are 
relatively good (MOH, 2014a). Healthcare services are effective especially when 
Comparing health outcomes in the GGs to those in the region, where progress in many 
health outcomes is remarkably noticed (World Bank, 2011b). According to the MOH, life 
expectancy at birth in West Bank and Gaza reached 73 years, compared to 71 years as the 
average of Middle East and North Africa and 81.1 years in the OEDC countries (MOH. 
2014a; World Bank, 2012; OEDC, 2013). It is accepted that the GGs view a status of 
"epidemiological transition" where mortalities are shifting from communicable diseases to 
no-communicable ones (MOH, 2014a). Data show that the leading causes of death are 
chronic conditions, namely heart diseases, cancer, perinatal conditions, and cerebro-
vascular conditions, while infectious diseases contributed at 4.7% of the leading causes of 
death (MOH, 2012). Nevertheless, poverty-related diseases and illnesses, such as 
malnutrition, anemia and other psychological illnesses also exist.  Regarding mental health, 
chronic violence, economic deprivation, social and cultural disparities had created 
psychological pressure on Palestinians. People often mention feeling hopeless and 
frustrated (World Bank, 2010). The ongoing psychological pain has resulted in a Jack of 
hope that has been translated into mental discomfort, domestic violence and a high rate of 
divorce, in addition to increased levels of anxiety, emotional numbness and psychosomatic 
reactions (MOH, 2014a). 
1.6.3.1 Disability in Palestine 
In 2011 data showed that around 113 thousand individuals suffered from at least one 
disability which constitutes 2.7% of the total population of Palestine: 75 thousand in the 
West Bank 2.9%, and around 38 thousand in Gaza Strip 2.4%. By gender, 2.9% are males 
and 2.5% are females (PCBS, 2011). 
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- Seeing disability/difficulty according PCBS 
Individuals who have some difficulties in vision that limits their ability to perform their 
daily duties, for example, may not be able to read, or see road signs while driving a car, 
may not be able to see well with one eye, or tunnel vision, or problem with vision that they 
perceive to be a problem. All individuals are asked whether they wear glasses or not, and 
must be reminded to wear glasses or contact lenses (PCBS, 2011). 
Seeing disability is the third highest prevalence disability comprising 21.6% of disabled 
individuals in the Palestine Territory: 21.9 % in the West Bank compared to 21.3 % in 
Gaza Strip (PCBS, 2011). 
1.6.4 Health care system 
The initial mentioned demographic characters of the Gaza Governorates population mean 
that there is an increasing load on the health sector which should respond not only to the 
current challenges of occupation, siege and political divisions but also to the increasing 
demands for health services resulted from the ongoing increase in population size (PNGO, 
2009). 
Although availability of four health provider's Ministry of Health (MOH), United Nations 
Relief and Works Agency (UNRWA), Non-Governmental Organizations (NGO) and the 
private for-profit service providers all share in the provision of health services at different 
levels (MOH, 2014).   MOH is the principal health care provider and serves as a regulatory 
body for the healthcare system in the governorates; it provides primary, secondary and 
tertiary services for the whole population, also it purchases advanced medical services 
from the neighboring countries and other private and NGO health care facilities by 
referring patients. 
1.6.5 Hospitals in Gaza Strip  
According to Health annual report data of 2011, the number of operating hospitals in the 
Palestinian Territory were 81, 51 hospitals in the West Bank, and 30 in Gaza Strip. The 
number of hospital beds in the Palestinian Territory were 5 414, representing 1.3 beds for 
every 1000 person, 3 163 in the West Bank and 2 251 in the Gaza Strip. Data from report 
2011 also showed that 25 hospitals were governmental and 56 were nongovernmental 
hospitals. On the other hand, 2011 data showed that the Gaza strip has 20 general, 6 
specialized, 3 Maternity and one rehabilitation hospitals. 13 of these hospitals were run by 
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MOH, 12 by nongovernmental sector, 3 military hospitals and 2 by private sector. They 
were distributed as 15 in Gaza zone, 6 in the North, 5 in khanunis, 3 in Rafah and 1 in the 
mid zone. 
1.6.6 Ocular care services 
Eye services developed gradually in MOH, it was provided within a small department at Al 
Shifaa Hospital till 1972, then Al Nasser Ophthalmic Hospital (NOH) was established to 
deliver ocular services to citizens from all over GGs (NOH, 2012 a). 
Regarding MOH hospitals, ocular services provided in an expanded manner through 
mainly two hospitals, (NOH) &European Gaza hospital (EGH) (MOH, 2012). 
NOH is the central hospital for eye care in Gaza Strip; it provides surgical and clinical 
services in addition to emergency and primary care through many ophthalmology sub 
specialties and departments (NOH, 2012 a), while in EGH eye services provided through 
ophthalmic department at the hospital which established in 1999 to serve south Gaza strip. 
Both hospital's services delivered through ophthalmologist, general practitioners, 
optometrist practitioners in addition to supporting nurse staff, anesthetists and pharmacists 
(MOH, 2012). 
1.6.7 Al Nasser Ophthalmic Hospital (NOH) context 
NOH considered as the first governmental surgical and clinical hospital, which provides 
eye services for citizens from all GG, and it is accredited as a training center for specialty 
of Ophthalmology by the Palestinian Medical Council (NOH, 2012 a). NOH consists 
mainly of two parts; clinical and surgical, in addition to emergency department.  
The annual report at the end of 2014, the hospital provided services for total 112156 
patients. Department of emergency received 71655 patients (Male - 39823), (Female - 
31831), distributed among GG as the following: North Gaza 18149, Gaza 48993, Middle 
zone 3656, khanunis 579, Rafah 278. Total number of 40501 patients received services at 
NOH outpatient clinics (Male - 18922), (Female - 21579), distributed as the following 
among GG: North Gaza 10132, Gaza 22380, Middle zone 5273, khanunis1705, Rafah 
1011 (NOH, 2014).  
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In the beginning of 2015, NOH started different subspecialty services through eight units 
in out clinic department, Retina unit, Cornea unit, Glaucoma unit, Cataract unit, Pediatric 
unit, Laser unit, Oculoplastic unit, and General unit (NOH, 2015). 
NOH includes optometry department, which emerged in ocular services at MOH in 2008, 
consists of two refraction units, contact lens's unit pediatric and squint unit, prosthesis unit 
and diagnostic unit. At the end of 2014 optometry department provided services to the total 
number of 5073 patients, 3083 Health School students 1990 in addition to many a service 
at out clinic department units and emergency department (NOH, 2012 a). 
Surgical department consists of three major operation rooms and one minor operation 
room, at the end of 2014 NOH provided (Minor operations 11228), (Major operations 
4388). NOH consists of the following professionals: Ophthalmologists 22, Nurses 37 
Optometrists practitioners 13, General practitioners 8, Pharmacists 4, Antitheists 1, 
Antitheists assistance 4, in addition to 28 employees working in administrative department 
(NOH, 2014). 
1.6.8 European Gaza hospital 
European Gaza Hospital (EGH) was established in 1999 on an area of 65 thousand meter 
squares. Located in the eastern side of Khan Yonis City, EGH provides different medical 
specialties, including medical and surgical services with a total bed's capacity of 246 beds. 
In 2013; the total number of admitted cases was 17648 cases; bed occupancy rate was 
82.4%, bed residency rate was 4.33 days (MOH, 2013). 
EGH considered as the second governmental surgical and clinical hospital, which provides 
eye services for citizens from south area of Gaza. EGH consists mainly from two parts; 
clinical and surgical, in addition to emergency department. 
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1.7 Operational Definitions 
Quality of Life: 
WHO defines Quality of Life as individual's perception of their position in life in the 
context of the culture and value systems in which they live and in relation to their goals, 
expectations, standards and concerns. It is a broad ranging concept affected in a complex 
way by the person's physical health, psychological state, a level of independence, social 
relationships, personal beliefs and their relationship to salient features of their 
environment. (WHO, 2012). 
Operationally, QOL refer to the response of glaucoma patient on the domains of the QOL 
as measured by the scores obtained using SF-36 and GQQL-15 instruments. 
Glaucoma: 
Glaucoma is a multifactorial ocular disease with characterized by progressive degeneration 
of the optic nerve and visual field loss. (Foster et al., 2002; Quigley, 2011). 
In this study, it refers to the case of glaucoma diagnosed by ophthalmologist and identified 
through medical record. 
Level of QOL: 
High level QOL: from (75 -100 %), Moderate (medium) level QOL: from (50 -75 %) 
Low level QOL: from (below 49 %) from WHO (1995) manual. 
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Chapter (2) Literature Review 
2.1 Conceptual framework 
The Conceptual framework is considered a basic component of the scientific research. It 
represents the infrastructure of study. It connects and explains the relationship between the 
dependent and the independent variables. The conceptual framework of the study as shown 
in Figure 2.1 illustrates variables that interact and affect the quality of life among 
Glaucoma patients. All these factors interact in different degrees with each other, 
consequently, affecting QOL either positively or negatively. 
Figure 2.1: Conceptual framework 
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2.1.1 Patient related variables  
Demographic characteristics: include age, gender, educational level, marital status, and 
residency. These factors directly affect patient QOL.  
Socioeconomic characteristics: include income, and employment status. These factors have 
a direct effect on patient QOL.  
2.1.2 Health profile variables 
Health Profile Variables include the type Glaucoma, Duration of the disease, 
comorbidities, another ocular disease, compliance with treatment. These factors directly 
affect the patient QOL.  
2.1.3 QOL dimensions 
2.1.3.1 Sort Form-36 Domains 
Physical Component: It includes physical functioning, physical role, bodily pain and 
general health.  
Mental Component: It includes vitality, social functioning, emotional role and mental 
health. 
2.1.3.2 Glaucoma Quality of Life -15 Domains 
GQL-15 Component: It includes: Central vision, Peripheral vision, Outdoor mobility, 
Glare and Dark adaptation   
2.2 Literature review 
2.2.1 Glaucoma 
Glaucoma is a progressive, chronic optic neuropathy that may result in a functional loss of 
vision (i.e., visual impairment); it is the second-leading cause of blindness worldwide. 
Glaucoma is typically characterized by increased intraocular pressure, retinal nerve fiber 
and optic nerve damage, and progressive loss of visual fields (Anderson, 2006; Cassin et 
al, 2006). It is usually referred to as the ‗silent thief of sight.‘. 
2.2.1.1 Epidemiology 
The number of people with glaucoma worldwide is expected to rise from 64 million to 76 
million in 2020 and 111 million in 2040, with Africa and Asia being affected more heavily 
than the rest of the world. (Tham, 2014). Primary open angle glaucoma is the most 
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common form of the disease worldwide. The highest prevalence of Primary Open Angle 
Glaucoma (POAG) are in African countries. 
Glaucoma prevalence is difficult to determine due to differences in defining disease, 
expertise of measurer, and diagnostic equipment. A 2014 review of worldwide POAG 
prevalence among people aged 40-80 years showed estimates of 2.31% in Asia, 3.65% in 
Latin America and the Caribbean, and 4.20% in Africa. (Tham, 2014). A review that 
focused on multiple Asian populations found that the prevalence of POAG ranged from 
0.5% in a Mongolian population to 3.9% in a Japanese group. (Cho, 2014; Foster et al., 
1996; Iwase, 2004). Another study, based in West Africa showed a POAG prevalence of 
nearly 15% in individuals over the age of 80. (Budenz, 2013). 
In the Arab world, there is no complete reliable data on the exact prevalence of glaucoma 
despite for some researches that were criticized by other researches due to limitation of 
inclusion criteria and classification of types of glaucoma. 
Here in Gaza strip, there is no reliable published data regarding the prevalence of 
glaucoma and glaucoma subtypes. The approximate number do not represent 12% of the 
real cases due to under registration problem. However, expectations from many doctors 
interested in this issue estimate that the majority of cases of glaucoma are open angle 
glaucoma (Almost 70% of all cases) without precise provision or classification of POAG 
or PACG subtypes. 
People with a familial history of glaucoma are among the most at risk for developing the 
disease. Race and age are statistically significant risk factors. Glaucoma is most prevalent 
in China, India, and Europe (Quigley & Broman, 2006). 
Additional risk factors strongly associated with a severity of glaucoma include myopia, 
hyperopia, cardiovascular disease, diabetes, eye injury, and the use of cortisone steroids 
(Dahl, 2013; Schuman, 2008). 
People with glaucoma show characteristic behavior that is the consequence of both 
changes in vision and of the increased effort to overcome challenges in daily living to 
maintain their independence. It is critical to know that people are typically unaware of 
changes in their vision as the result of glaucoma until later stages of the disease 
progression, a point at which constant vision loss has already occurred. 
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As described in the quality of life researchers, driving, mobility, involvement in the 
community (crossing the road, reading street signs), reading, adjusting to different levels of 
illumination, contrast sensitivity, judging distances, and peripheral vision-dependent tasks 
were affected by glaucoma (Goldberg et al., 2009; Nelson, & Aspinall, 1999; Ramulu, 
2009; Ramulu, et al., 2012; Spaeth, 2006; Viswanathan et al., 1999). 
Alterations in mobility were characterized by slower walking and reaction times, impaired 
perception of motion, and bumping into objects located in the periphery (Kuyk et al., 1998; 
Turano et al., 1999; Viswanathan et al., 1999) 
Notable that, people with severe glaucoma involved additional value to the integrity of 
their central vision in the advanced stages of the disease than they did in the early stages of 
the disease (Spaeth et al., 2006). This reveals the pathological progression of the disease; 
that the central visual field is commonly not compromised until the advanced stages. 
2.2.2 Classification of glaucoma 
At this time, glaucoma is classified into primary and secondary. In primary glaucoma, the 
optic neuropathy is the consequence of primary defects in the circulating pathway of 
Aqueous Humor (AH) or within the neural retina or the ganglion cells themselves. In 
secondary glaucoma, the optic neuropathy or glaucomatous symptoms occur due to some 
other ocular or systemic disease or defects.  
Major types of primary glaucoma 
1. Primary open angle glaucoma (POAG)/chronic open angle glaucoma (COAG): 
Currently, the idea that high IOP is the exclusive cause of optic neuropathy has been 
almost discarded, 
 since in many patient's optic neuropathies occurs at normal IOP (Foster al., 2002; Quigley, 
2011). POAG is now defined as significant optic nerve damage in the eye, which does not 
have evidence of angle closure on gonioscopy, and where there is no identifiable secondary 
cause. POAG is the most prevalent type of glaucoma. 
2. Primary closed angle glaucoma (PCAG): Patients having narrow or closed anterior 
chamber angle associated with significant obstruction of trabecular meshwork and 
glaucomatous optic neuropathy. PCAG can be subdivided into subacute, acute, chronic, 
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symptomatic or asymptomatic according to the nature and severity of the onset. The 
worldwide prevalence of PCAG is about one-third of the rest (Quigley and Broman,2006) 
Secondary glaucoma may occur under many ocular or systemic conditions like: 
1. Uveitis 
2. Ocular trauma 
3. Ocular neovascularization 
4. Thyroid orbitopathy 
2.2.3 Causes of glaucoma 
Glaucoma is an age-related condition. There may be no single cause of glaucoma. Some 
significant risk factors have so far been identified. Elevated intraocular pressure is the most 
important risk factor. Glaucoma is commonly, but not exclusively, associated with an 
increase in intraocular pressure (IOP), and optic nerve damage may be a response to 
chronically elevated IOP and mechanical deformation (Hernandez, 2000; Johnson et al., 
1996). 
2.2.4 Consequences of glaucoma 
Damage to retinal nerve cell's results in damage to the field of vision; the peripheral field is 
generally damaged first. Due to our eyes overlapping visual fields and the minor role 
peripheral vision plays in most people's perception of what they see, sight loss may not be 
noticed until it has reached a significant level. Deterioration usually progresses slowly, 
over years, although some types of secondary open-angle glaucoma may progress more 
rapidly. 
2.2.5 Risk factors for glaucoma 
The major risk factors for glaucoma are: 
» Age: incidence increases with age, most commonly presenting after the age of 65 and 
rarely before the age of 40 years; Older age is strongly related to glaucoma. Both incidence 
and prevalence increase with age (de Voogd et al. 2005; Leske et al. 2008), and older age 
is also a risk factor for glaucoma progression (Lichter et al. 2001; Chauhan et al. 2008b). 
» Family history: Glaucoma in first- or second-degree family members is a risk factor, 
regardless of IOP (Hulsman et al. 2002; Leske et al. 2008).  
» Race: Prevalence of glaucoma is higher in people of African descent than in those of 
European ancestry (Leske et al. 1994). 
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» Raised IOP. Elevated IOP is the most important risk factor for both development (Kass et 
al. 2002) and progression (Heijl et al. 2002) of glaucoma. 
2.2.6 Diagnosis and detection 
It is expected that more than half the people with glaucoma in the developed world and 
90% in the developing world have not been diagnosed early (Wittenborn and Rein, 2011; 
Burr et al, 2007). 
Patients are often referred with a raised IOP, but this is not diagnostic of glaucoma. 
Evaluation of these patients includes: 
 Measurement of IOP using a Goldman applanation tonometer mounted on a slit 
lamp. 
 Measurement of the central corneal thickness (a thicker cornea may not be as 
indentable as a cornea of normal thickness, so the pressure inside the eye may be as 
high as it appears. Conversely, a thinner cornea may give an inaccurate low 
pressure reading) 
 Visualization of the drainage angle using a special contact lens known as a 
gonioscopy lens. 
 Visual field measurement using a standardized program. 
 Assessment of the optic nerve through a dilated pupil using a slit lamp. 
 Optic disc imaging should also be carried out, and the images should be available 
for all future visits to facilitate the detection of optic disc change. Imaging may take 
the form of standard photography or other modalities such as optical coherence 
tomography. (NICE, 2009). 
Accurate diagnosis is difficult, particularly early on, and patients are often examined 
several times before diagnosis is made. High pressure is not indicative of glaucoma 
without changes in the retina. Glaucoma is usually associated with a rise in IOP but 20-
52% of people with the condition have a ―normal‖ IOP (≤21mmHg); this is known as 
normal tension glaucoma. Conversely, some people with a ―high‖ IOP (>21mmHg) do not 
develop glaucomatous changes and are classified as having ocular hypertension. These 
patients are monitored as some do develop glaucoma. 
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2.2.7 Monitoring of Glaucoma 
Glaucoma is a lifelong condition with a varied course. Monitoring is required to ensure 
control is stable, note changes and implemented treatment changes. Complete, accurate 
notes must be available at every clinic visit to ensure transfer of information between the 
community and hospital ophthalmic services, and stability of care. 
2.2.8 Impact of glaucoma on visual function 
Visual Functions we are referring to the performance of the visual system, more or less in 
isolation, under standardized measurement conditions. visual functions are measured using 
quantitative clinical tests. The specific visual functions include:  
Visual acuity, Visual fields, Contrast Sensitivity, Color vision, Binocular Function. 
The progressive damage of retinal nerve fibers from glaucoma leads to decrease in visual 
field, and the more nerve damage determines the severity of visual field loss. Primarily, 
glaucoma results in the reduction in peripheral visual field sensitivity and is the leading 
cause of visual field loss in the older population (Ramrattan et al., 2001). 
In its early stages, reduced visual field sensitivity often goes unnoticed by the patient, until 
central vision is affected. Due to this and the progression of the disease, a large number of 
the population with glaucoma is undiagnosed and remains unaware of their condition 
(Weih et al., 2001; Friedman et al., 2004). 
Central vision can also be affected in advanced stages of glaucoma, resulting in loss of 
visual acuity, contrast sensitivity and depth perception. Also, Contrast sensitivity is also 
impaired with more advanced glaucoma. 
2.2.9 Economic burden of Glaucoma 
The prevalence of glaucoma contributes to significant costs that are both direct and 
indirect. (Rein DB et al., 2006). Direct medical costs include ocular hypotensive 
medication(s), physician and hospital visits, and glaucoma-related procedures while direct 
nonmedical costs include transportation, government purchase programs, , and nursing 
home care. Indirect costs reflect lost productivity, such as days missed from work, and can 
include the productivity costs borne by caregivers such as family members and friends. 
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The average direct cost of glaucoma treatment ranges from $623 per year for patients with 
early-stage glaucoma to $2,511 per year for patients with end-stage disease (Lee PP et al., 
2006).  
In view of the Palestinian reality, we find that the economic situation is very bad which led 
to an increase in poverty and unemployment and lack of availability of medicines and all 
due to the Israeli occupation of the Gaza Strip, all these factors led to that glaucoma 
patients in Gaza are suffering too, so they cannot get access to essential medicines for the 
disease. Which led to deterioration of the condition in patients with glaucoma in the Gaza 
Strip and the results that the quality of life in patients less than other studies. 
Patients mention three main barriers to treatment (1) a poor understanding of glaucoma, (2) 
the financial burden of medication, and (3) side effects of treatment. These obstacles 
contribute to poor adherence and increase the risk of blindness.  
In summary, the economic burden of glaucoma is significant and increases as the disease 
worsens (Varma et al., 2011).  
2.2.10 Treatment  
Treatment is aimed at achieving constancy, defined as no evidence of progression or 
progression at a rate at which visual impairment does not affect the quality of life. 
Moreover, the goal of treatment is saving vision by preventing more retinal nerve fiber 
degeneration and visual field loss. (Burr et al., 2007). If glaucoma is not progressing or is 
doing so very slowly, no treatment may be needed; in other patients, an aggressive or 
rapidly progressing disease can make treatment difficult. Treatment focuses on reducing 
IOP as this is the modifiable risk to retinal damage. Once a patient is diagnosed, a target 
IOP is established; this is the level the clinician believes is low enough to prevent disease 
progressing to a level that would impair the quality of life. Younger patients are likely to 
have to live with glaucoma for longer and so are given a lower target IOP than older 
patients (NICE ,2009). 
Some, particularly older patients with very slow-progressing disease may be monitored 
without treatment as the disease is unlikely to cause disability in their lifetime. Progression 
at any age will necessitate changes in treatment.  Benefits of reducing or stopping 
treatment may include removing the burden of regular medication. Drug therapy is the 
usual first treatment of choice; patients are started on single eye-drop therapy, with extra 
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drops added if the IOP does not reach the target. If a patient is on the maximum tolerable 
treatment, laser or surgical options may be considered (NICE, 2009). 
2.2.10.1 Drug treatment 
The first-line treatment is usually prostaglandin analogue drops, which reduce IOP by 
increasing outflow of aqueous humor via the uveoscleral route (which usually only 
accounts for 10% of drainage). It may affect pigmentation of the iris and periorbital skin, 
and lash growth. These drops have the fewest side-effects of the drugs used to treat 
glaucoma. Second-line treatment is often the addition of a beta blocker to reduce aqueous 
humor production. Prostaglandin analogues and beta blockers may be given together to 
reduce the number of drops the patient must instill. Combination therapy also minimizes 
the amount of preservative entering the eye, thus reducing the risk of intolerance or allergic 
reactions. Preservative- free drops are also available. 
All drugs have contraindications and side-effects, and regimens may change depending on 
the patient‘s systemic and ocular responses (Patient.co.uk, 2014). Patients at risk of sight 
loss despite treatment may have surgical and laser procedures, including Trabeculotomy 
and Trabeculectomy, which reduce IOP by artificially increasing drainage of the aqueous 
humor through the trabecular meshwork by means of laser or surgical tissue removal. 
2.3 Quality of Life 
2.3.1 History of QOL in medicine 
The term QOL started to be used in the early 1960s after changes in the health and the 
demographic profiles of ―late modern‖ societies. Public health agenda in the first half of 
20th century was developed and articulated to help cope with the complex forms of 
mortality, the incidence, and prevalence of morbidity.  
In other words, medicine focused its attention on a quantity of life. In the 1960s, there 
emerged another issue: quality of life. QOL was first mentioned in a medical field by 
Elkington in 1966. In the 1970s the term QOL started to be used in medicine as noted by 
Sharon Wood-Dauphinee (Wood-Dauphinee et al., 1999).  
In 1977, QOL became a keyword in the Medical Subject Headings of the US National 
Library of Medicine MEDLINE Computer Search System. When QOL was introduced 
among the MeSH (Medicines Subject Headings), it was defined as ―a generic concept 
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reflecting a concern with the modification and enhancement of life attributes, e.g., 
physical, political, moral and social environment; the overall condition of a human life‖ 
(Pennacchini et al., 2011). 
QOL measures moved from being research issues for economists and others, to be 
explored by managers and the new specialists in public health medicine as potential 
attentions to guide health policy. Instead of providing more resources to meet needs, a 
better quality of services could be aimed at, within properly managed funds. 
Thus, researchers focused their interests in the construction and testing of instruments 
designed to measure health and QOL. Medical social scientists faced major methodological 
challenges in developing a measure of QOL. 
The researchers had achieved an agreement on the relevant factors of QOL among 
physicians, nurses, patients, family and others who were concerned about the patient. 
The academic study of the patient‘s QOL received considerable attention, but it produced 
an argument about the relevance and feasibility of such investigations. 
The development of new measures continued through the 1990s. During these two 
decades, methodological accuracy improved through the development of psychometric 
properties measurement (Wood-Dauphinee et al., 1999).  
First, scientists developed generic and multidimensional questionnaires to acquire broad 
information on large groups of patients. Then, they developed disease-specific 
questionnaires aimed at evaluating the functional abilities of patients. (Pennacchini et al., 
2011). At the same time, these questionnaires showed still some conceptual and 
methodological problems that made it difficult to use QOL in medicine. 
Researchers did not build a conceptual model or a theory as a foundation for the construct 
of QOL that would allow clarifying relationships among its components. The field had 
been severely criticized for the lack of science in QOL research, which confused the 
understanding of what was being measured and what it meant (Gill et al., 1994). 
In 1994, Albrecht wrote that theoretical work had lagged instrument development and 
validation because QOL research has largely developed inductively. So, in the mid-1990s 
there was a new attempt to define QOL with greater care. 
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It must be distinguished that changes in the concept of health, which had occurred during 
the second half of the 20th century had extremely affected and modified the idea of QOL: 
the concept of health had undergone major changes, passing from negative health measures 
such as the five D‘s - death, disease, disability, discomfort, and dissatisfaction -, towards 
more positive domain and features (Pais-Ribeiro et al., 2004). 
World Health Organization (WHO) definitions of health and QOL are positively-oriented: 
health is considered ―a state of complete physical, mental and social well-being and not 
merely the absence of disease or infirmity‖ (Whoqol Group et al., 2005). And from this 
new perspective on health have stemmed more positive measures aimed at assessing health 
and disease. 
These new health measures have, in turn, affected the concept of QOL, which was defined 
by WHO in 1995 as individual‘s perception of their position in life in the context of the 
culture and value system in which they live and in relation to their goals, expectations and 
standards and concerns. It is a broad-ranging concept affected in a complex way by 
person‘s physical health, psychological state, a level of independence, social relationship, 
and their relationships to salient features of their environment. 
Despite these wide-ranging definitions provided by the WHO, there was no generally 
agreed definition of QOL. It should be noted that, among those research articles, some do 
provide a definition of the concept, but others do not, and some even attempt to measure 
the degree of QOL in various types of people, patients, population, etc., without proposing 
a conceptual definition. Whether a definition has been provided there has been, through the 
years, an increasing focus on QOL, that has resulted in a huge number of relevant 
publications in the scientific literature: ―A PubMed search of articles published from 1966 
to 2005 identified 76,698 articles containing ‗quality of life‘ as a Medical Subject Heading 
or as a title or abstract term. Since the mid-1960s, the number of publications on this 
subject has grown exponentially‖ (Moons et al., 2006). 
Some believed that variability across cultures, between patients, and in the same patient 
over time made efforts to define the term QOL impossible. They considered QOL as a 
mystery, so they thought that physicians and economists could avoid QOL assessment 
(Leplege et al., 1997). 
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In its place, other researchers believed that QOL was useful in introducing the patient‘s 
viewpoint into clinical practice and decision processes (Frank et al., 1998) and others 
proposed a new method for generic measuring of global QOL (Ventegodt et al., 2003). The 
idea that the patient‘s perspective is as valid as that of the clinician when it comes to 
evaluating outcomes had much of legitimacy and should certainly not be abandoned. 
However, in recent years there has been a call for the explanation of this term within the 
medical context, more specifically health-related quality of life (Farquhar, 1995). 
2.3.2 Definition of QOL 
Quality of life is a progressively important subject both in scientific research and patient 
care. This increasing approval can be explained by the broad recognition that QOL is a 
highly relevant outcome measure in medical treatment, establishing an important addition 
to the traditional biomedical endpoints such as limitations in the functioning of organs, 
senses, or limbs or mortality (De Vries, 2001). 
Since the early 1970s, concern in the QOL concept has raised significantly in clinical 
practice and research. QOL has been of dominant importance for evaluating the quality and 
the outcomes of health care. Despite its value, there is still no consensus on the definition 
or proper measurement of QOL.  
There is no agreement about the definition of quality of life. Some articulate that there 
is more misunderstanding on what quality of life means than on any other concept in 
social, medical, and psychological research (Dijkers, 2005). 
Currently, social researchers evaluated quality of life by assessing socioeconomic 
status, housing, education, and neighborhoods. Agreement definition of quality of life 
has not been reached because the quality of life is an ambiguous concept and a multi-
axis term (Bowling, 2001). 
WHO defines QOL as "an individual's perception of their position in life in the context 
of the culture and value systems in which they live, and in relation to their 
goals, expectations
,
 standards and concerns. It is a broad-ranging concept affected in a 
complex way by the person's physical health, psychological state, level of 
independence, social relationships
,
 and their relationships to salient features of their 
environment" (WHO, 2012 Bowling, 2003).  
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Two aspects to this definition are mostly important. First, it shows that QOL is a subjective 
concept that refers to positive as well as negative aspects of life, and second, QOL appears to 
be a comprehensive and multidimensional concept. 
Health care professionals thus should give special attention to not only the influence of the 
disease or handicap on the everyday functioning of their patients (that equal health status), 
but also to their patients‘ satisfaction with their physical, psychological, and social 
functioning (that equal QOL) (De Vries, 2001; De Vries and Drent, 2006). 
Defining QOL in terms of satisfaction with life is most suitable. It reflects the degree 
to which a person completely evaluates the overall subjective and objective 
components of his or her life. Furthermore, QOL refers to the level of enjoyment and 
satisfaction with the life led so far. Other definitions of QOL have been to emphasizing 
components of happiness and satisfaction with life (Fayers et al, 2001). Raphael et al., 
(1996) quality of life as: the degree to which a person enjoys the important possibilities of 
his or her life. 
Diverse sciences focus on aspects of QOL, representing their own discipline, within 
nursing sciences and medicine. The focus in QOL is the relation to different degrees of 
health, symptoms, illnesses and treatments because these are the domains of the 
health care professionals (Pinar, et al, 2003).  
QOL is a broad, complex and multidimensional concept, which includes an assessment of 
the ability of the patients to meet their needs and how they react to the limitations they 
face. It is therefore, subjective, individualized and difficult to measure but its assessment is 
crucial to a holistic understanding of patients. 
QOL has been developed as a worldwide concept that is affected by several factors.  To, it 
is considered that individuals are the only ones who can dependably estimate their own 
QOL (Ferrans, 1996). Situation of individuals, religion and culture influences it (Patel, 
2006).  
QOL is affected by the environmental, socio-economic and health conditions in which an 
individual finds himself. The dimensions of QOL include psychological health, physical 
health, social relationships and environment. 
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2.3.3 Definitions of "Health-Related Quality of Life" 
There are many diseases or health conditions, including eye diseases, that can affect a 
person‘s health-related quality of life (QOL), which refers to ―the extent to which patients‘ 
perceived physical and mental functioning is affected on a day-to-day basis by a chronic 
disease‖ (Centers for Disease Control and Prevention). 
Although experts continue to disagree on the definition of quality of life, there seems to be 
a consensus that Health-Related Quality of Life (HRQOL) considers the level of physical, 
psychological, and social functioning, and that it includes abilities, relationships, 
perceptions, life satisfaction, and well-being. (Wood-Dauphinee, 1999) 
Researchers are not concerned in quality of life in its wide sense in health research, thus, 
the term "Health-Related Quality of Life" was brought in. HRQOL been defined as a 
multidimensional construct, it emerged to highlight the effects of health, illness and 
treatment on quality of life, (Bowling, 2001), while health according to WHO definition 
can be considered as "a state of complete physical, mental, and social well-being, not 
merely the absence of disease and infirmity". 
In similarity with the WHO definition of health, health-related quality of life refers to 
the overall conditions of quality of life of ill or healthy subjects in harmony with the 
following eight domains: limitations in physical activities because of health problems, 
limitations in social activities because of physical or emotional problems, litigations 
in role activities because of physical health problems,  general mental health, 
limitations in role activities because of emotional problems,  bodily pain,  vitality, and 
general health perceptions of an individual or a group measured in terms of feelings of 
satisfaction or dissatisfaction (Ware and Sherbourne, 1992). 
Health-related QOL is the functional effect of a medical condition and its consequent 
therapy for a patient. It is an important indicator which when measured can be used to 
quantify the degree to which a disease, and its treatment affect the patients‘ life. 
The measurement of health-related quality of life is a subjective assessment of one's own -
welfare- a perception to the degree of satisfaction with an ability to perform and 
control different facets of one's life (Molassiotis et al., 2001). 
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Its measurement together with traditional clinical measures takes a more comprehensive 
picture of the burden of disease experienced by patients. 
Ophthalmologists and optometrist use the term (vision-related QOL) to distinguish the 
fact that their area of primary interest is the effect of visual loss or impairment and the 
treatment of eye disease on patients‘ ability to function optimally.    Vision- related 
QOL has been defined as ‗a person‘s satisfaction with their visual ability and how their 
vision impacts on their daily life‘ (Asaoka et al., 2011). 
Several multidimensional factors influence QOL. The socio-demographic characteristics 
of individuals (age, gender, and educational status), life experiences and culture may 
affect an individual‘s QOL. Individualized characteristics such as patient‘s nature , 
personality (Warrian et al., 2009) and life expectations also influence QOL. Interest in 
general health-related QOL measures in health research has led to the development of 
questionnaires which examine the physical, emotional and social aspects associated with 
a disease. 
These multidimensional instruments measure the impact of health problems on general 
health status, and allow for a common metric to compare between different diseases. It 
should be noted that the HRQOL can be assessed using either a generic or   a disease -
specific questionnaire, the WHOQOL and Medical Outcomes Study short form health 
surveys, SF-36 are an example of a generic HRQOL questionnaire. These questionnaires 
are designed to measure the most important aspects of HRQOL.  
2.3.4 Interest of studying quality of life 
Quality of life was considering a significant factor in the examination of patient 
responses to disease and treatment. In last two decades, the concept of quality of life has 
more and more applied to study and evaluate the health status of patients suffering from 
chronic illnesses (schalock, 2004). 
Schalock also pointed out that the concern in quality of life has come from four sources. 
First, increasing need of customer empowerment and patients' rights has led to 
interested-on patient-centered care that quality of life is an element of that. 
Second, the huge development of medical technology may have led to improve quality 
of life to raise understanding of the welfare of person, family and community.  
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Third, provide good care puts the community services under the pressure to evaluate 
and measure the results of quality of life for individual's enhancement in the 
community. 
Four, the presence of research within the field of sociology has introduced the perceptual 
aspects of quality of life, and the individual characteristics involved producing the need for 
additional research. 
The requirement to include patients' empowerment, family involvement and support as well 
as the availability of community services led to increase interested to study QOL. Strength of 
mind quality of life allows for benchmarking of the disease across populations. This 
provides an improved understanding of the burden of disease that patient's knowledge 
and is informative to providers, clients, families, and others.  
Measure the effect of treatment by using QOL focusing on the viewpoint of the patient 
provides opportunities to tailor therapies. (DeSalvo et al., 2006 and Dominick et al., 
2002).  Finally, improve patient-provider communication has been shown by use of 
quality of life in order to create a more patient-centered environment (Velikova et al., 
2004). 
2.3.5 Uses of quality of life 
Quality of life is the most notable client outcome measure in health outcome research 
to evaluate and thereby improve the quality of health care provided for the patients 
(O'Connor, 2004). 
Frist, to encourage health care providers and direct the health care providers to areas of 
the patient's concern and to ask about specific aspects of the health and well-being of 
their patients (O'Connor, 2004). 
Moreover, to examine the effect of health program and distribute the health care 
resources appropriately and evaluate the effect of clinical therapies; the consequences 
of treatment and treatment-related side effects may influence patients' life. (Bowling, 
2001 and O'Connor, 2004). 
Also, to give a complete appraisal of a personal health and well-being, apart from 
physiological measures (Dempster and Donnelly, 2000). 
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Finally, to enhance the communication, exchange of idea and interaction with 
patients by collect information about patients' conditions. SO, the clinicians can 
communicate with patients and understand the consequences of patient's illness and its 
treatment (O'Connor, 2004). 
2.3.6 Measurement of QOL 
QOL needs to be considered when evaluating the knowledge and outcome of patients 
receiving health care because it's an important parameter. This is particularly the case for 
patients with long term chronic diseases, since a complete cure from their illness is 
often impossible (Macduff, 2000). 
Additionally, there is arising from need for global principles to measure QOL in a way 
that allows comparisons across cultures. In the meantime, the global standards must be 
relevant to individual cultures. The known differences between Western and Eastern 
cultures may be reflected on the QOL measurement results (Ayoub, 2012). 
QOL is multidimensional and highly subjective and for this reason, its measurement is 
difficult. QOL questionnaires are also called tools, or instruments. They measure multiple 
characteristics referred to as scales, or domains and are comprised of questions known as 
items. QOL assessment tools are quantitative measures, which allow comparable, 
reproducible, responsive and valid functional health status determination to be made. 
Measurement of QOL is done using either preference based or functions based 
instruments. 
 Preference based instruments assess the value placed by patients on their QOL while 
function based tools use items to grade the degree of difficulty patients experience while 
performing vision-related tasks (Aspinall et al., 2007). 
QOL domains may differ depending on the questionnaire being used or the research 
question being studied but essentially, most questionnaires try to include aspects of life, 
which may affect the quality of one‘s life. 
QOL is measured by administrating a questionnaire formed by items or questions to 
participants whose QOL is of interest. Most often, each item is answered on a Likert 
scale. The items are grouped into several domains. Each domain refers to a scope of 
behavior or experience. 
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2.3.6.1 QOL domains: Annex (2) 
 Felce suggests 6 possible QOL domains based upon a synthesis of life domain 
areas (Felce, 1997). 
 Schalock proposes 8 core dimensions in his conceptual model of QOL. (Schalock, 
2000). 
  Keith refers to the consensus that has developed internationally around Schalock‘s 
model (Keith, 2001) 
  The World Health Organization QOL Assessment comprises 6 domains. The 
(WHOQOL Group, 1995). 
 Hagerty et al proposed 7 domains (Hagerty et al 2001) 
 Lastly, Cummins proposed 7 core domains (Cummins, 1997) 
2.3.6.2 Benefits of QOL Measurement for Glaucoma  
Measurement of QOL in glaucoma patients is essential for several reasons. Primary open 
angle glaucoma (POAG) which is commoner than angle closure glaucoma in most popula
tions, is essentially symptomless, can lead to irreversible blindness if untreated and requir
es lifelong follow up irrespective of the treatment modality employed. There is no cure fo
r glaucoma and vision loss from glaucoma cannot be restored to the level of knowledge a
vailable at present although research is on-going. 
The goal of treatment in glaucoma is therefore, to improve clinical outcome by 
preventing further progression of the disease and ultimately preserve or improve the 
patients QOL. 
It is impossible to preserve or improve something that has not been measured. This is 
even more important in a disease like glaucoma where some treatment effects may only 
be detectable by patients. 
QOL assessment has the following advantages: 
  It improves the doctor‘s understanding of patient‘s challenges with performance 
of everyday tasks needing good vision. 
 It makes information about how glaucoma affects QOL and how these effects are 
modified by treatment. This information is useful for patient counseling, which 
helps patients make informed treatment choices during their management (Mills, 
1998). 
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 QOL assessment process may help evaluate the economic impact of current and 
new therapies. 
 May contribution in assessing the quality of care given to patients. 
 It can be used to quantitatively assess patient‘s satisfaction or to detect increasing 
visual burden. 
 It can assist clinicians suspect other problems if there is a discrepancy between 
QOL scores and severity of disease. 
2.3.6.3 Types of QOL measurements: 
Global, generic, and specific instruments represent three different types of measures in the 
assessment of quality of life (Wiklund et al., 2000) 
-  Global measures 
Those types are designed to measure QOL in a comprehensive or an overall manner. A 
single question can be asked to someone to rate his or her QOL or an instrument such as 
the Flanagan QOL scale that asks people to rate their satisfaction on 15 domains of life 
(Eljedi, 2005). 
- Generic measure 
The Generic type has much in common with the global type and designed mainly for 
descriptive purposes. In health care, they point out to the impact of an illness or its 
symptoms on the patient's life. Generic measures are applicable to a wide range of 
populations (WHOQOL-BREF instrument). 
The main advantage is their broad coverage, and they allow compressions of different 
patients or cross studies. On the other hand, their disadvantage is their inability to address 
topics of relevance for a given disease (ELjedi, 2005). 
- Specific measures 
These types come to complete the side of specificity related to many health conditions and 
diseases. This has led in the development of condition or disease specific questionnaires. 
These focuses on a problem within a group of patients such as pain, fatigue, and physical 
functioning. These types are useful for monitoring specific problems eligible for an 
intervention (ELjedi, 2005). 
2.3.6.4 QOL Assessment Tools for Glaucoma  
Various instruments have been developed and used to measure QOL of Glaucoma patients 
(Annex 3 show Tools types and uses).  
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The researcher uses general health questionnaire (SF-36) and Glaucoma specific 
disease (GQL-15).  These instruments have been used because they cover all domains 
related to quality of life and have been appropriate for the Palestinian reality and 
suitable for the data that we will collect from the sample as well as the information that 
can be obtained from the patient file. 
2.3.7 The Short Form-36 questionnaire  
The Short-Form-36 questionnaire instrument used to assess and approve 
intervening methods to improve quality of life. 
The Short-Form-36 questionnaire focuses on the participant's experiences, feelings, 
beliefs, perceptions and convictions concerning their health-related quality of life during 
the past four weeks. It consists of closed-ended structured questions. These questions 
are related particularly to the eight quality of life indicators and two summary measures 
that revolve around both the physical and mental health. Close-ended questions of the 
Short Form-36 questionnaire force participants to establish their responses from a range 
of possible answers (Stark and Roberts, 2002). 
The Short-Form-36 questionnaire also allows one to access three main goals of both the 
natural and social sciences (Henslin, 2003) 
The questionnaire enables the researcher/practitioner to predict or determine the 
possible outcomes regarding the quality of individual health and life. 
The Short-Form-36 questionnaire provides possible solutions to improve health-related 
quality of life in each of the eight dimensions by suggesting possible intervening 
methods or programs. 
2.3.7.1 The eight health-related quality of life dimensions assessed by Short Form-36 
questionnaire 
The eight health-related quality of life dimensions assessed by the Short Form-36 
questionnaire includes: 
1- General health: This dimension assists the perception of the individual's general 
health. It is measured in terms of concepts such as excellent, very good, good, fair or 
poor, getting ill easier than other people or just as healthy as anyone he/she knows (Ware, 
1993). 
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2- Emotional roles limitation: The scores on this dimension assess the extent to which the 
emotional condition of the participant, e.g. feeling depressed or anxious, limits his/her 
daily functioning and ability to perform roles, such as cutting down the -length of time used 
up on work ether activities and accomplishing less than he or she would like to (Ware, 
1993). 
3- Physical functioning: The scores on the physical functioning domain scale refer to the 
extent to which the participant's perceptions of their quality of life are affected by 
their physical condition. In the first example, physical functioning indicates the extent to 
which the respondents can perform dynamic activities such as running, lifting heavy 
objects, participating in strenuous sports, climbing several flights of stairs and walking 
more than a kilometer. In the second case in point, it involves the performance of 
moderate activities such as bending, kneeling, bathing and dressing (Ware, 1993). 
4- Social functioning: This dimension refers to social activities and interaction 
significantly with others such as family members, friends, neighbors and other 
social relations (Ware, 1993). 
5- Physical roles limitation: This dimension attributes to the degree to which 
participant's performance of their roles in daily activities hindered by their physical state 
of health; for example, their ability to perform dynamic activities such as lifting heavy 
objects or to perform moderate activities such as moving a table or pushing a vacuum 
cleaner (Ware, 1993). 
6-  Mental health: This dimension of the respondent is measured in terms of the extent 
to what the participants are feeling nervous, downhearted and blue and feeling calm and 
peaceful also a happy person (Ware, 1993). 
7- Vitality: The scores on this dimension indicate to what extent the respondent's 
experience of feeling active and full of energy, or worn out and tired (Ware, 1993). 
8- Bodily pain: The dimension indicates to what extent the participant's experience 
of bodily pain reduces their performance of daily activities, involving work-related duties 
in the public environment and tasks within the home (Ware, 1993). 
2.3.7.2 Advantage of Using SF-36 Questionnaire 
The SF-36 is a comprehensive approach also encourages individuals to enhance their QOL 
by becoming involved in joint decision-making and coordinated implementation strategies 
(Sato and Smith, 1996). The comprehensive approach of the SF-36 questionnaire 
encourages us to ask whether a health-related assumption is indeed true, and to question 
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those incorrect and inaccurate assumptions we are challenged with, regarding health and 
QOL (evaluate the truth) (Macionis, 2003). 
Secondly, the SF-36 questionnaire is to assess the entire health-related situation of 
individuals, by concentering on the way in which they define and experience their QOL. 
Finally, a comprehensive approach promotes the empowerment of the individual in 
emphasizing the individual's ability to take control over his or her own QOL, through 
acting and by accepting responsibility for such actions (Sato and Smith, 1996). 
2.3.8 Glaucoma Quality of Life-15 Questionnaire 
Many of the glaucoma-specific questionnaires or instruments have been developed in the 
past two decades. The Glaucoma Quality of Life-15 (GQL-15) questionnaire is concise and 
easy to administer. (Nelson, 1999; Nelson, 2003) 
Independent reviews have described it as one of the better glaucoma-specific instruments, 
with good acceptability among clinicians and patients. (Walt, 2011) Initially derived from 
a 62-item pilot instrument, the 15 itemGQL-15 was first described in 2003. These 15 items 
were selected based on their strong relationship with visual field loss in glaucoma patients. 
Several studies have used the GQL-15 (Goldberg, 2009). 
The name for the instrument suggests that the trait under measurement is vision-related 
quality of life; however, all the items refer to activity limitation (near vision, peripheral 
vision, mobility, and dark adaptation) (Nelson, 2003). 
The Glaucoma Quality of Life-15 questionnaire asks 15 rating-scored questions to assess 
the degree of functional disability caused by glaucoma. The questions used were the 15 
most significant predictors of visual field loss derived from an original 62-point 
questionnaire. They include six questions relating to actions demanding functional 
peripheral vision, six relating to dark adaptation and glare, two relating to central and near 
vision and one relating to outdoor mobility. 
The GQL-15 is a 15 item, the 4-domain tools that are short and easy to use. The instrument 
is based on the premise that perceived visual disability that significantly associated with 
binocular visual field loss. It has good internal consistency and reliability. The tool has 
been shown to demonstrate that difficulties in everyday life are mirrored by poor 
performance in several psychophysical tests. (Spaeth, 2006) 
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2.3.8.1 The Four Glaucoma-quality of life dimensions assessed by GQL-15 
questionnaire 
1- Central vision: The scores on this dimension assess the extent to which the 
central vision of the participant, e.g. Newspaper reading, recognizing faces were 
affected by glaucoma. 
2- Peripheral vision: The scores on this dimension assess the extent to which the 
Peripheral vision of the participant, e.g. Tripping over an object, seeing objects come 
from the side, walking in steps/ stairs and Bumping into objects were affected by 
glaucoma. 
3- Outdoor mobility: The scores on this dimension assess the extent to which the 
Outdoor mobility of the participant, e.g. Crossing the road were affected by 
glaucoma. 
4- Glare and dark adaptation: The scores on this dimension assess the extent to 
which the Glare and dark adaptation of the participant, e.g. Walking after dark, 
seeing at night, adjusting to bright lights and Findings dropped objects were affected 
by glaucoma. 
2.4 QOL and Glaucoma 
2.4.1 Factors Affect QOL among Patients with Glaucoma Disease 
2.4.1.1 Demographic and Socioeconomic factors  
Gender 
Many researcher studying QOL take the gender of the study sample subjects as a very 
important factor affecting QOL. For example, in the study of Tran HM et al., (2011) who 
conducted a population-based study in Nigeria to assess associations of visual function 
(VF) and quality of life (QOL) by visual acuity (VA), causes of blindness by VF/QOL 
questionnaires among 2076 participants reported that the women had worse QOL 
compared to men. Also, Lim et al., (2016) conducted a study to assessment of Depression, 
Anxiety, and Quality of Life in Singaporean Patients with Glaucoma reported that a 
relatively high prevalence of depression (30%) and anxiety disorders (64%) among 
glaucoma patients in Singapore. Female glaucoma patients are more likely to suffer from 
depression.  
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Moreover, Tastan et al. (2010) conducted a study to investigate the relationship between 
anxiety, depression, and quality of life in patients with glaucoma. Case-control study was 
carried out with 121 participants with glaucoma (M age=64.2, SD=13.2; 68 women, 76.0% 
married) and 64 controls by using (NEI-VQ25). The result showed that the anxiety risk in 
women with glaucoma was found to be 7.5 times higher than in men in Turkish patients 
with glaucoma. In contrast, Labiris et al. (2010) conducted a cross-sectional study in 
Greek to assess the vision-specific quality-of-life (VS-QOL) of Greek glaucoma patients, 
and the impact of potential influencing factors by using (NEIVFQ -25) 121 patients. The 
result found that female glaucoma patients had worse QOL (lower NEIVFQ scores) than 
male patients. Also, Jain et al. (2015) conducted a study to assess quality of life of 
glaucoma patients as per WHOQOL-Brief among 100 patients, reported that QOL of male 
better compared to female except in (social domain) female better than male.  
Age 
With population aging, the number of people with visual impairment and blindness is 
rapidly growing, as many eye diseases are more widespread among the elderly. (Bourne et 
al. 2013). The main causes of visual impairment were cataracts, refractive error and 
glaucoma and Visual impairment was found to be associated with advancing age (s 
Oluleye et al. 2014). Also, Goldberg et al. (2009) conduct study to measure and compare 
quality of life in patients with and without glaucoma using the Glaucoma Quality of Life-
15 Questionnaire, and to determine the association between glaucoma-related quality of 
life and clinical indices of glaucoma. Using a prospective, cross-sectional study, we 
collected demographic information via interviews and administered the questionnaire to 
assess glaucoma-related quality of life in 121 patients with glaucoma and 31 subjects 
without glaucoma. The result showed that the younger glaucoma patients have greater 
vision-related problems than older patients with glaucoma. 
Education level 
Many studies reported that not only was reported happiness associated with income and 
being employed but was also for highly educated. Odberg, T et al, (2001) who conducted 
a cross-sectional study to evaluate the feelings and experiences of patients living with 
glaucoma using a self-administered questionnaire, A total of 589 questionnaires were 
returned. The result show more than 80% reported negative emotions on learning that 
they had glaucoma, so giving a patient a diagnosis of glaucoma influences his quality of 
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life negatively and found that less educated patients were more afraid of going blind from 
Glaucoma. Also, Zhou et al. (2014) that‘s conduct study to assess vision-related quality of 
life (VRQOL) in Chinese glaucoma patients and explore its sociodemographic, clinical and 
psychological correlates by GQOL-15 reported that QOL of patients with high education 
was better in all four domains. 
Marital status   
Some have argued that human need is the foundation for QOL. As can be seen marital 
status reported in many studies as a factor paly role in affection QOL. 
From Tran HM et al., (2011) who conducted a population-based study in Nigeria to assess 
associations of visual function (VF) and quality of life (QOL) by visual acuity (VA), 
causes of blindness by VF/QOL questionnaires among 2076 participants, reported that 
married respondents had better QOL scores than unmarried ones. Also, Zuo et al. (2015) 
conducted a study to assess Vision health-related quality of life in Chinese's glaucoma 
among 202 patients using Chinese-version low vision quality of life questionnaire 
(CLVQOL) reported that VRQOL of married glaucoma patients was probably better than 
that of patients who were unmarried. 
Income  
Adequate income has implication for health, education, nutrition, opportunity for leisure 
and social participants. Higher level of QOL (well-being) have been reported to be 
associated with higher income. Jain et al. (2015) who conduct study to assess quality of 
life of glaucoma patients as per WHOQOL-Brief among 100 patients, reported that QOL 
of patients with high income was better, and Poor quality of life in all four domains was 
found to associate with lower income. 
2.4.1.2 Health profile factors  
Compliance with treatment 
Glaucoma patients are more likely to be adherent to their medication if they understand the 
disease and the rationale for treatment and if their treatment regimen is simplified (Robin 
et al., 2011). The fear of blindness can have several effects on the patient‘s attitude. It may 
create a healthy care that makes the patient extremely compliant and adherent to drug 
usage and follow-up visits which is useful. Loon, S. C et al, (2015) who conducted A 
cross-sectional, prospective study, using interviewer-administered survey questionnaires 
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to (I) To evaluate the medication adherence rate of glaucoma patients in Singapore. (ii) 
To evaluate patients' quality of life status. (iii) To explore the factors related to patients' 
nonadherence to medication for 314 patients, Patients' quality of life was evaluated using 
Glaucoma Symptom Scale and The Glaucoma QOL questionnaire. The result showed 
that the full-adherence rate is low among glaucoma patients. Having less beliefs in the 
need for and more concerns about their medication are the 2 factors associated with 
nonadherence, and Nonadherence has an association with decreased quality of life. 
Duration of the disease 
Duration of disease could lead to the extension of suffering from the consequences and 
progression of glaucoma. vanGestel, et al, (2010) who conducted a cross-sectional study 
in seven hospitals at Netherland to investigate the relationship between visual loss in 
glaucoma and HRQOL by using (EQ-5D), (VFQ-25) and (GQL-15) for 537 patients. The 
result found that visual acuity, side effect. Glaucoma surgery independently affects 
HRQOL, and it's important to prevent progression both in early and advance glaucoma. 
Also, Skalicky et al, (2008) undertook a study to determine the prevalence of depression 
and its association with visual filed impairment, QOL and glaucoma severity. Cross-
sectional study among 165 patients by using (GQL-15), and the result showed prevalence 
were more with increasing glaucoma severity. QOL scores reflect a decrease QOL with 
increasing glaucoma severity (age, 70 to 79 y). 
In Nigeria, a hospital -based- cross sectional analytic study to evaluate the quality of life 
of (POAG) for 132 patients by (NEIVFQ25), (GQL-15). The result from the study 
showed that POAG patient had to reduce QOL even in the early stages, and clear trends 
of worsening QOL with increasing severity of disease.  Onakoya et al, (2012) 
Presence of other (ocular – chronic) disease 
Other chronic conditions also produce problems in pain and discomfort or daily activities, 
Therefore, visually impaired patients with other chronic conditions maybe have more 
problems in a greater number of daily activities. Lin et al. (2010) conduct A retrospective, 
nationwide, case-control study using an administrative database to Comparison of 
comorbid conditions between open-angle glaucoma patients and a control study, the study 
group comprised 76,673 OAG patients. The comparison group comprised 230,019 subjects 
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matched to the study cohort. The study showed that Open-angle glaucoma patients are 
significantly more likely to have comorbidities. 
Also, Sung et al. (2017) who conducted a study to evaluate vision-related quality of life 
in Korean glaucoma patients and to explore the associated factors. A total of 907 
Questionnaires (NEI VFQ-25) were collected. The result showed that the lower (NEI 
VFQ-25) Rasch score showed a significant association in the presence of other ocular 
diseases. 
2.5 Local studies on QOL 
Regarding to local studies reviews, apparently that no studies were conducted before on 
QOL among Glaucoma patients in GG, thus researchers compared the study results with 
results of available studies on QOL among different target populations. 
Elayyan (2007) conducted a study to evaluate the QOL among hypertensive patients 
attending governmental and UNRWA clinics. The researcher used a descriptive, analytical 
cross sectional design; the study sample included 340 patients aged between 40-71 years, 
who had hypertension at least for two years by used WHOQOL-BREF questionnaire. The 
results of the study revealed that the percentage of the total scores of the QOL among the 
whole study sample was (65.63%); the highest domain was the social (70.14%) while the 
lowest was the environmental (62.40%). Demographic characteristics, including age, sex, 
marital status, educational attainment, duration of disease, monthly income, family size, 
employment and clinic visited, were statistically significant except for some domains 
pertaining to some groups. Physical, psychological and social domains were lower in the 
group of monthly incomes of 300 NIS or more, in comparison with the group of monthly 
incomes of 2001-3000 NIS. Regarding the marital status, psychological and social domains 
were higher in the married group in comparison with divorced group, but the physical 
domain in the divorced group was better than that in the married group. 
Cross-sectional design study was conducted by Luzon (2008), aimed to examine the QOL 
and to identify most common factors influencing the QOL in long-term rehabilitated stroke 
survivors in GG, by using Short Form-36 (SF-36). The study shows that, the stroke 
survivors had good QOL with 55.6%.  The mental health was the best QOL domain 
(81.28%), followed by general health (77.77%), body pain (76.24%), and vitality (71.6%) 
almost similar with social functioning (71.39%).The poorer QOL domain was role 
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limitation due to physical health (28.05%), followed by physical function (40.89%), and 
role limitation due to emotional problems (42.97%). 
Hannoun (2012), a quantitative cross-sectional study aimed to investigate the perceptions 
of Ischemic Heart Diseases (IHD) patients in Gaza City regarding their QOL, and the 
factors influencing their life status, conducted, by using a self-constructed questionnaire, 
which focuses on a new aspect of QOL like lifestyle, severity of IHD and health care.  A 
convenience sample of 208 IHD patients from Al-Shifa medical complex were completed 
the questionnaire. Regarding participants' evaluation of their QOL level (global value); 
38% were rated their QOL as neither good nor poor, 24.5% were reported it as good and 
10.6% as very good, while 22.1% described it as poor and 4.8 % as very poor QOL 
(Hannoun, 2012). 
Khleif and Imam (2013) did a study in the three main hospitals - Beit Jala Governmental 
Hospital, Watani Governmental Hospital, and Augusta Victoria Hospital - for cancer care 
in the West Bank, between May 1, and July 31, 2012. Patients aged 18-90 years with 
cancer who attended the hospitals for treatment and follow-up were selected by convenient 
sampling and had qualitative in-depth interviews. Ten patients completed the qualitative 
in-depth interviews and 323 of 350 patients (92%) completed the cross-sectional 
quantitative questionnaire EORTC QLQ-C30.The QOL domains with poor scores (mean 
score 48·5) were: physical role (48·8), emotional role (46·0), and social functioning (50·0), 
whereas the scores were worse for financial difficulties (64·6) and for symptoms (fatigue: 
66·6, pain: 63·0 and insomnia: 56·4). These results were worse than those of patients with 
cancer in Kuwait, Turkey, and the UK (Khleif and Imam, 2013). 
Al-Nahhal, (2013) conducted a descriptive, analytical cross-sectional study in GS. The 
general purpose of the study was to assess the QOL among end - stage renal disease 
patients undergoing hemodialysis in Gaza Governorates through administered 
questionnaire (WHOQOL-BREF questionnaire) with a response rate of 97%. The total 
score of QoL among ESRD patients at mean 76.12, and results showed that,55% of study 
participants revealed negatively about their quality of life, where 20%of participants rated 
their quality of life positively and 25% of them responded fairly. Moreover, 57% of the 
total samples were satisfied with their health, where 23% of patients were dissatisfied with 
their health. The results indicated that, the environmental domain gets the highest score 
Moreover, the lowest domain was physical with relative weight was 55%. 
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Abu-Muammar, (2014) conduct descriptive, analytical, cross-sectional study to o assess 
QOL among patients with thalassemia disease in Gaza Strip. Study has been performed on 
200 thalassemia patients aged 18 years or more on follow-up at two hematology centers by 
using Short Form-36 (SF-36). The results showed that study participants had a medium 
perception level of QOL (mean score was 41.98, SD=19.24). The overall mean percentage 
for SF-36 domains scores ranged from 24.68% to 53.85%. The general health domain got 
the highest score with relative weight equaled 53.85%, the social function domain: 
51.78%, the physical function domain: 50.62%, the bodily pain domain: 49.90%, the 
mental health domain: 33.19%, the vitality domain: 32.70%, the emotional role limitation: 
31.88% and the lowest domain were physical role limitation with relative weight of 
24.68%. 
In our current study, we compared the results of local quality of life studies with the results 
of our study. (Figure 2.2) showed that the Thalassemia patients had a lower score of QOL 
while better score for Hypertension disease. Moreover, Glaucoma was on medium level 
compared with other diseases. 
 
Bayoumi (2014) conduct a mixed-method approach (triangulated) study to assess the 
status of wellbeing of GG population, and explore its correlates among people aged 15 to 
65. Study has been performed on 627 community members aged 18 years to 65 through 
administered questionnaire (WHOQOL-100 questionnaire).  
Finding reveal that 67.6% of participants were married and 30.6% were working at the 
time of data collection. Nearly two thirds (64%)of respondents reported that their 
households 'Income was less than NS 1600 per month. Only, 2.2% of respondents 
classified themselves as rich, while 27% had considered themselves as poor or very poor, 
more than half (59.2%)of the surveyed house received aids from various sources. Of the 
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Figure 2.2 : Quality of life in the Gaza Strip among different diseases
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total respondents, 83.2% perceived themselves as enjoying good health, 17.2% reported 
having chronic diseases, and 7.8% reported having disability. Although, around 90% of 
respondents possess health insurance, yet, 43.9% of respondents reported spending more 
than NIS 50 a month on health care.  
Of the total respondents, 22% thought that people around are happier than them. Around 
one third (35.4%)explicitly declared their support to certain political parties. The majority 
of respondents (86%)reported that they can share and express their opinions openly in the 
Front of Family members. But neither al public nor at work places. Security wise, 36.2% 
of respondents were seriously worried  
The overall perceived wellbeing was relatively better than the previous findings of local 
studies which targeted specific groups of patients. The overall wellbeing of the study 
participant 73.2 (moderate), with a clear variance between spiritual and level of 
independence aspects which elicited the highest scores (around 80% each) and the 
environment domain (65%)which scored the least. Alarmingly, 15.6% of respondents 
reported considering leaving the country as one of their options for the future.  
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Chapter (3) Methodology 
3.1 Study Design 
This study is a descriptive, analytical cross-sectional study to assess quality of life 
among glaucoma patients. The researcher chooses to implement this design because it is 
the best design to describe the QOL. This type of study is quick, cheap and easy to 
conduct. It enables the researcher to meet the study objectives in a short time. (Martins et 
al., 2005). 
3.2 Study population 
In this study, the population is those patients with glaucoma diseases who are registered in 
Al Nasser Ophthalmic Hospital (NOH) and European Gaza hospital (EGH). 
The target population in hospitals is estimated about: (1001-1200) patients in NOH, (201-
300) patients in EGH, from the unit of statistics in a NOH and EGH  hospitals. 
3.3 Study settings 
This study has been conducted at two main centers providing eye care for Glaucoma 
patients. First, AL Nasser Ophthalmic Hospital and second, European Gaza hospital. 
3.4 Study Period 
The total study period was ten months from May 2016 to February 2017. During this 
period, a range of activities had been started: title selection, proposal preparation and 
presentation, data collection, data cleaning, data analysis, and printing. 
3.5 Eligibility criteria  
3.5.1 Inclusion criteria 
 Patients with glaucoma whose age was 18 years or more.  
 Patients agreed to give consent and are able to respond to the questionnaire. 
3.5.2 Exclusion criteria 
 Patients who do not meet the inclusion criteria were excluded from the study. 
 Presence of cognitive, hearing disability. 
3.6 Sample of the study  
Sample size taken by using the method of convenience sampling, in the way that 
guarantees the accessibility to the sample member and eligibility of research.  
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The researcher used Decision Analyst statistical program to calculate the sample size at 
maximum acceptable percentage points of error 5%. The sample size was (299) of the 
glaucoma patients at desired confidence level 95%. (Annex 4). 
3.7 Study Instruments 
3.7.1 The Health Survey Short Form (SF-36): The Short Form-36 health survey item, 
was used for this study to assess quality of life. The Short Form-36 survey is a well-
recognized, self-administered quality of life scoring system. (Annex 5). 
3.7.1.2 Scoring the SF 36-Item 
The SF-36 items describing the eight health concepts were transformed into a score of 0-
100, and the item's scale averaged to obtain a subscale score. Physical component 
summary and mental component summaries were computed by averaging the values of the 
respective subscales. A higher score indicated higher levels of function and better health.  
Scoring the SF-36 questionnaire is a two-step process. In the first step, preceded numeric 
values are recoded per the scoring key is given in (Annex 6). All items are scored so that a 
high score defines a more favorable health state. In addition, each item is scored on a 0 to 
100 range so that the lowest and highest possible scores are zero and 100 respectively. 
Scores represent the percentage of total possible score achieved.  In step 2, items in the 
same scale are averaged together to create the 8 scale scores. Items that are left blank 
(missing data) are not considered when calculating the scale scores. Hence, scale scores 
represent the average for all items in the scale that the respondent answered. (Ware, 1993). 
The score given to QOL in each domain varies between zero and 100; a score close to zero 
imply a worse QOL while the one close to 100 shows a better QOL (Brazier et al., 1992).  
This questionnaire has eight scales. Each scale contains several items to meet the questions 
of study instrument. (Annex 7) shows the components combined within scales for SF-36. 
3.7.2 Glaucoma Quality of Life-15 Questionnaire: It is one of the better glaucoma-
specific instruments, with good acceptability among clinicians and patients. (Annex 8) 
3.7.2.1 Scoring the GQL-15 -Item 
Higher GQL-15 scores indicate poorer QOL. The GQL-15 item level responses were 
coded on a scale of 0 to 5. (5) represented severe difficulty due to visual reasons, (1) 
indicated no difficulty with performing the activity, and (0) signified abstinence from 
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activity for nonvisual reasons. Summation of the item response scores of the GQL-15 
provided the summary scores. To calculate the subscale scores for the four domains of the 
GQL-15, the item level responses were scored on a numerical interval scale ranging from 
(0) indicating no difficulty, to (100) indicating severe difficulty. The subscale score for 
each domain was calculated using an average of the scores generated in the component 
item-level responses. Higher subscale scores were indicative of increasing difficulty with 
vision-related activities and poorer QOL. A measure of the degree of difficulty in 
performing visual tasks outlined in the GQL-15 was depicted by corresponding visual 
performance (Nelson et al., 2003). 
But the researcher to reverse the results for GQL-15 and became the results as follows 
scale ranging from (100) indicating no difficulty, to (0) indicating severe difficulty. Lower 
subscale scores were indicative of increasing difficulty with vision-related activities and 
poorer QOL. 
Researcher explained the inverse results, in order to be a consensus among the two 
questionnaires, and also that, the highest value is the best in quality of life. 
3.8 Scientific rigor and trustworthiness   
3.8.1 Reliability:  
To ensure reliability, during the pilot study, test-retest was conducted with 5 participants in 
the first stage piloting by the researcher. Checking and verification the filled questionnaires 
have been done at the end of data collection, so error identification, correction and 
prevention were more feasible.   
The psychometrics of the questionnaires were tested twice through the statistical analysis 
software Statistical Package for Social Sciences (SPSS) and indicated high reliability 
Cronbach's Alpha rating ranging (0.74-0.86) for SF-36 and (0.75-0.87) for GQL-15 
Reliability of the collected data of each domain and the total scale are presented below.  
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Table 3.1: Reliability estimates for domain and the entire scale (SF-36) and (GQL-15) 
 
 
 
 
 
3.8.2 Validity:  
The questionnaires (English and Arabic versions) were constructed through adapting 
previously tested instruments in order to best serve the study objectives. Then the 
constructed tools were validated through eight expert reviewers who advised regarding 
internal content validity and appropriateness for statistical analysis to ensure content 
related validity. The questionnaire was nicely formed to ensure face validity.  
3.9 Pilot study 
A pilot study on 30 patients was done to assess the adequacy of the data collection plan, to 
explore whether respondents understand the questions, to minimize the problems which 
may rise during data collection, to identify all domains and components of instrument and 
to determine the exact time needed to fill the two questionnaires. 
3.10 Response Rate 
According to the eligibility criteria, the researcher selected 299 patients whose age was 18 
years or more to participate in the study. A total number of 265 patients agreed and 
participated, which represented (88.6%) of the study population while 34 patients refused, 
which represented (11.4%) of the population. 
3.11 Ethical and administrative considerations 
 An academic approval has been obtained from the School of Public Health at Al-Quds 
University (Annex 9), 
SF-36 Scale Items Alpha   
Physical functioning 10 0.86   
Role functioning/physical 4 0.75   
Role functioning/emotional 3 0.79   
Energy/fatigue 4 0.81   
Emotional well-being 5 0.85   
Social functioning 2 0.84   
Pain 2 0.78   
General health 5 0.74   
GOL-15 Scale Items Alpha   
Central vision 2 0.87   
Glare and dark adaptation 6 0.75   
Outdoor mobility 1 0.80   
Peripheral vision 6 0.82   
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 An official latter of approval to conduct the research to be obtained from the Helsinki 
committee- Gaza strip (Ethical committee). (Annex10) 
 An official latter of approval from MOH to collect data from hospitals. (Annex11) 
 The researcher assured the respondents that all the findings of the study would be used 
to guide the service providers and policy makers to improve QOL for Glaucoma 
patients. 
 To guarantee participants rights, a covering letter indicating that the participation is 
voluntary and confidentiality was assured for all of them. 
3.12 Data collection 
 Data was collected through face-to-face Short Form-36 questionnaire interview, 
Glaucoma Quality of Life-15 Questionnaire and from patients' files. 
 All questionnaire forms were prepared, organized, and classified with serial 
numbers to ensure the availability of the needed information 
 The researcher gave the participant suitable time to answer the questions and 
encourage them to be open and honest in answering while promising them that 
information given to the interview has remained confidentiality and just used for 
the study. 
 Great care has taken to ensure privacy and confidentiality. 
 The researcher explained the purpose of the questionnaire to the patients before 
obtaining consent and during the interview, any unclear information was simplified 
by the researcher to ensure the exact and real answer by the patients. 
3.13 Data analysis: 
 Statistical Package of Social Science (SPSS) program version 20 was used for data 
entry and analysis. 
 Descriptive statistics such as means, medians, cross tabulations were used to show 
sample characteristics differences.  
 Inferential statistics, t-test and ANOVA, were used to find the relationship between 
QOL dimensions and other independent variables.  
3.14 Limitations of the study 
1-Difficulties in finding cases (time-consuming process) 
because we have just 2 days in a week to meet patients in NOH and 1 day in EGH  
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2-Lack of previous studies, especially QOL studies in Arab countries. 
3- Difficulties in collecting of the data from sick or tired patients. 
4-Lack of essential information in medical patient files (Visual Field test, Ocular 
Coherence Topography test) which lead the researcher to exclude the vision variable 
(visual acuity, visual filed). 
In the NOH, Visual field test was available and complete in 26.6%, but not available in 
62.0% of files, and recommended but still not recorded in 11.4%. Such a gap in visual field 
testing documentation is not accepted in a glaucoma management pathway; reflecting a 
weak diagnosis and monitoring process of glaucoma progression in checked files. She 
attributed the Gap to unavailability of a visual field analyzer at NOH. In addition, OCT 
was available and complete in 13.3%, but not available (77.8%), recommended under 
investigations 8.9%. Even though OCT was available at NOH, but the extended waiting 
lists in a diagnostic clinic among diabetic retinopathy and glaucomatous patients lead to 
ignoring it and depending mainly on a direct ophthalmoscope test (Habib, 2016). 
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Chapter (4) Results and Discussion 
Introduction  
This study has been conducted at NOH and EGH to assess the QOL among patients with 
Glaucoma disease in GS, using the Short Form-36 (SF-36) questionnaire and Glaucoma 
quality of life -15 (GQL-15). 
This chapter presents the study findings; it shows main findings of the statistical analysis, 
and the answers to the research questions. Moreover, the study results discussed and 
argued in the light of the previous studies.  
 The first part includes descriptive statistic's findings 
 The second part includes inferential statistic's findings 
The results could contribute in evaluation and understanding individual's perceptions that 
receiving glaucoma services at MOH hospitals in GG. 
4.1 Characteristics of the study participants (n=265) 
Table 4.1: Distribution of the frequency of the demographic and socio-economic and 
health variables of the study participants, (n=265) 
Demographic Data 
 
No. % 
Sex   
Male 147 55.5 
Female 118 44.5 
Total 265 100.0 
Age    
18 to 30 Years old 23 8.7 
31 to 40 Years old 27 10.2 
More than 40 Years old 215 81.1 
Total 265 100.0 
Education   
Illiteracy 29 10.9 
Primary and Secondary 91 34.3 
Tertiary 99 37.4 
University 46 17.4 
Total 265 100.0 
Marital Status   
Not Married 30 11.3 
Married 235 88.7 
Total 265 100.0 
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Governorates   
North Gaza 50 18.9 
Gaza 137 51.7 
Mid zone 20 7.5 
Khanunis 41 15.5 
Rafah 17 6.4 
Total 265 100.0 
Place of receiving Services (hospital)   
NOH 180 67.9 
EGH 85 32.1 
Total 265 100.0 
socio-economic Data No. % 
Working   
Yes 70 26.4 
No 195 73.6 
Total 265 100.0 
Monthly Income   
Less than 1000 NIC 188 70.9 
From 1000 to 2000 NIC 54 20.4 
More than 2000 NIC 23 8.7 
Total 265 100.0 
Health Profile Data  No. % 
Type of Glaucoma   
OAG (primary & secondary) 251 94.7 
CAG (primary & secondary) 7 2.6 
Congenital  7 2.6 
Total 265 100.0 
History of Ocular disease 
Yes 103 38.9 
No 162 61.1 
Total 265 100.0 
History of chronic diseases   
Yes 145 54.7 
No 120 45.3 
Total 265 100.0 
Duration of disease   
Less than 5 Years 122 46.0 
From 5 to 10 Years 71 26.8 
More than 10 Years 72 27.2 
Total 265 100.0 
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compliance with treatment   
Yes 230 86.8 
No 35 13.2 
Total 265 100.0 
 
4.2 Demographic variables 
4.2.1 Gender 
The study results showed that 55.5% of participant (n=147) were male and 44.5% (n=118) 
were female. The subjects‘ gender characteristics are shown in (Figure 4.1). 
 
4.2.2 Age 
The age of participants was divided into three categories as following (18-30 years, 31- 40 
years, more than 40 years). Figure (4.2) showed the categories of age among participants. 
The maximum percentage was noted among patients aged more than 40 years, which 
represented (81.1%) while the lowest was noted among patients aged 18-30 years which 
represented (8.7%). 
Male 
55% 
Female 
45% 
FIGURE (4.1) PERCENTAGE DISTRIBUTION OF RESPONDENTS BY GENDER 
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Here, the researcher explains that the percentage of Glaucoma among the elderly is high 
compared to younger patients because Older age is strongly related to glaucoma. Both 
incidence and prevalence increase with age (de Voogd et al. 2005; Leske et al. 2008), and 
older age is also a risk factor for glaucoma progression (Lichter et al. 2001; Chauhan et al. 
2008b). 
4.2.3 Educational level 
As shown in Figure (4.3), most of the participant were at tertiary educational level 
(37.4%), followed by Primary and Secondary level which represent (34.3%), university 
and higher educational level represent (17.4%), while illiterate represented only (10.9%). 
 
4.2.4 Marital status 
Figure (4.4) represented marital status for glaucoma patients. Most of them 88.7% (N=235) 
were married, single represent (5.7%), and the others were widowed and divorced (5.7%). 
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300
8.7% 
10.1% 
81.1% 
Figure (4.2) Percentage distribution of respondents by  Age 
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Figure (4.3)  represents the educational status of the study participants.
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4.2.5 Distribution according to Governorates  
According to "Governorates" the result showed that most of glaucoma patients lived in 
Gaza city (51.7%), followed by North-Zone (18.9%), Khanunis (15.5%), Mid-Zone 
(7.5%), and the lowest percentage was lived in Rafah city which represented (6.4%). 
(Figure 4.5)   
NOH hospital is the first main Glaucoma care unit in GS in which (67.9%) of patients with 
Glaucoma disease are treated. This resulted in presence of the highest number of patients 
from this hospital in the study. It provides services to patients from North governorate, 
Gaza governorate and Mid-zone governorate. The EGH is the second main unit, which 
takes care of (32.1%) of Glaucoma patients. It provides services to patients from Khanunis 
and Rafah governorates. 
 
235 
15 15 
Figure (4.4) presented marital status for the Glaucoma patients 
married single widowed and divorced
0
50
100
150
137 
50 
41 
20 
17 
Figure (4.5)  Percentage distribution of Glaucoma patients by 
governorate 
Gaza North-Zone Khanunis Mid-Zone Rafah
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4.3 Socio-demographic Data 
4.3.1 Monthly income and Employment 
According to the work, the study results represented 73.6% (N=195) of the participant 
were not working, while (26.4%) of them were working. 
The monthly income divided into three main categories: less than 1000 NIS, 1001-2000 
NIS, and more than 2001 NIS. 
The highest percentage was found in patients with income less 1000 NIS (N=188; 70.9%) 
who live under poverty level, followed by patients who have income between 1001-2000 
NIS (20.4%), and the lowest percentage was found in a patient who has income more than 
2001 NIS (8.7%) (Figure 4.6) 
 
 
4.4 Health profile variables 
4.4.1 Type of Glaucoma 
According to the type of Glaucoma from a file of the patients, most of the patients were 
Open Angle Glaucoma (primary and secondary) 94.7% (n= 251), while 2.6% (n=7) Close 
Angle Glaucoma (primary and secondary), while Congenital Glaucoma represented only 
(2.6%). 
4.4.2 Duration of disease 
As illustrated in figure (4.7), 46.0% (N=122) Less than 5 years, (26.8%) From 5 to 9 year, 
(27.2%) More than 10 years. 
less 1000 NIS 1001-2000 NIS more than 2001 NIS
188 
54 
23 
Figure (4.6)  Percentage distribution of Glaucom patients by monthly income
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4.4.3 History of ocular disease and chronic disease 
According to history of ocular disease, the study result showed that 38.8% (n= 103) of 
participants had a history of ocular diseases, while 61.1% (n=162) don't have history of 
ocular diseases, and 54.7% (n=145) of a participant have history of chronic diseases, while 
(45.3%) don't have history of chronic diseases. 
4.4.4 Compliance with treatment  
According to compliance with treatment, the study result showed that (86.8%) of 
participant have compliance with treatment ; while (13.2%) not compliance with treatment. 
Figure (4.8) indicated that most of Glaucoma patient commitment with the treatment. 
 
4.4 Quality of Life Domain (SF-36 Analysis) 
QOL consists of eight core domains including 35 items. The last (36th) item is an 
additional question correlated to changes in health status during the past years. The results 
of the analysis of SF-36 questionnaire were divided into eight domains. These include: 
general health, mental health, physical functioning, physical role limitation, emotional role 
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limitation, bodily pain, vitality and social functioning. The eight domains summary total 
results are divided into two groups (Mental Component Summary and Physical Component 
Summary). 
The Mental Component Summary (MCS) consists of vitality, social functioning, role 
limitation due to emotional problems, and mental health. The Physical Component 
Summary (PCS) consists from physical function, role limitation due to physical health, 
bodily pain, and general health.  
4.4.1 Patients' perspectives about their quality of life 
The table (4.2) shows that the mean score for the SF-36 subscales ranged from (79.4%) 
for bodily pain to (48.58%) for the general health. 
Table (4.2) Scores obtained in the SF-36 from patients with Glaucoma disease 
SF-36 Domain 
No. of 
Items 
Mean SD 
Physical Function 10 70.38 23.9 
Role limitation due to physical Health 4 55.75 27.3 
Role limitation due to emotional problems  3 58.24 32.1 
Energy / Fatigue  4 54.09 10.0 
Emotional well being 5 54.7 13.1 
Social Functioning 2 72.22 28.7 
Pain 2 79.42 33.3 
General Health 5 48.58 8.7 
Total SF– 36 domains 35 61.7 13.5 
The results showed that the lowest domain was general health with a mean of (48.58%) 
and the best domain score was bodily pain with a mean of (79.42%). The result indicated 
that glaucoma mainly affected the vitality of patients. Additionally, the results revealed 
that a mean score of Emotional wellbeing domain was (54.70%).  
Moreover, the results showed that the mean of the social function domain was (72.22%) 
which considered the second-best domain score. The total SF-36 finding showed a mean 
score of (61.7%) which describe that most of the participant had a medium level of QOL. 
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From a systematic review of studies that used the SF-36 survey to evaluate QOL in 
glaucoma patients, vitality was the most affected domain. General scores in the physical 
domains (i.e., physical functioning, role limitations-physical, bodily pain, and general 
health) were lower than those in the psychosocial domains (social functioning, mental 
health, vitality, and role limitations-emotional). 
4.4.2 Glaucoma and General health  
The perception of Glaucoma patient's general health is assessed in terms of concepts such 
as excellent, very good, good, fair or poor, and at the same time as healthy as anyone 
he/she knows, getting ill easier than other people, expect his/her health to get worse. The 
mean score of general health domain was (48.58%), which concerned the lowest QOL 
scores. 
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Table (4.3) Distribution of responses in reference to general health related item 
"General Health domain 
  Excellent 
Very 
Good 
Good Fair Poor 
Mean 
percentage 
General health No. 0 19 53 165 19 44.06 
% (0.0%) (7.2%) (20.0%) (62.3%) (7.2%) 
  Definitely 
True 
Mostly   
True 
Don‘t 
Know 
Mostly 
False 
Definite
ly 
False 
Mean 
Get sick easier than 
the other 
No. 4 
(1.5%) 
66 135 3 
(1.1%) 
57 54.06 
%  (24.9%) (50.9%)  (21.5%) 
Healthy as anybody 
I know 
No. 19 6 
(2.3%) 
189 49 2 49.15 
% (7.2%)  (71.3%) (18.5%) (0.8%) 
Exception health to 
get worse 
No. 36 127 46 53 3 36.79 
% (13.6%) (47.9%) (17.4%) (20.0%) (1.1%) 
Health is excellent No. 9 141 57 51 7 58.87 
% (3.4%) (53.2%) (21.5%) (19.2%) (2.6%) 
Results listed in Table (4.3) indicted that (62.3%) of participants shown good about their 
general health. Results also indicated that (7.2%) revealed poor and (20.0%) rated their 
QOL as fair. Furthermore, Results indicated that (10.6%) of the participants revealed very 
good. Although, glaucoma patients have medium level of general health. 
Nevertheless, A significant portion of participant (61.5%) expected poorer health in the 
future, and around (21.1%) of the participant expected good health in the future. 
Wu et al., (2014) who conducted a study Survey on vision-related quality of life and self-
management among patients with glaucoma found that the lowest scores were for general 
health (32.78). Moreover, Nordmann et al., (2003) who conducted a study to assess Vision 
related quality of life and topical glaucoma treatment side effects use NEI-VFQ-25 global 
score showed an overall good QOL and two domain scores showed some deterioration in 
(general health and driving) and found that the mean score general health of domain was 
(48.25). 
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Our Findings were consistent with McKean-Cowdin et al., (2008) who conducted a study 
to assess impact of visual field loss on health-related quality of life in glaucoma that found 
the mean score of general health of domain was (47.2%), Moreover The lowest mean 
average values were in "general health" (54.76) in a study to evaluate the vision-related 
quality of life of glaucoma patients (Orta et al., 2015). 
Moreover, Results of our study were consistent with Lin et al., (2010) who conducted a 
study in Taiwan to assess visual impairment and quality of life, the relationship between 
visual function and health-related QOL and to identify factors that are significantly 
impacting QOL for glaucoma patients, that found that the mean score general health of 
domain was (51.08), In addition, results were inconsistent with Evans et al., (2009) who 
conducted a study to assess the quality of life impact of peripheral versus central vision 
loss with a focus on glaucoma versus age-related macular degeneration which found it 
(69.7). 
For local studies of QOL in GGs, result of current study were consistent to (Abu-
Muammar, 2014) who conducted a descriptive, analytical cross-sectional study in Gaza 
governorate to assess the QOL among Thalassemia patients by using Short Form-36 that 
found that the mean score general health of domain was (53.85).  
In addition, Our Finding were inconsistent to (Luzon, 2008) conducted a cross sectional 
study to examine the QOL and to identify most common factors influencing the QOL in 
long-term rehabilitated stroke survivors in Gaza governorate, by using Short Form-36, that 
found that the mean score general health of domain was (77.77). 
4.4.3 Glaucoma and physical function 
The physical domain components are (perform vigorous activities such as running, lifting 
heavy objects, and perform moderate activities such as moving a table, and climbing 
several flights of stairs, Bending, kneeling, or stooping, and walking more than a 
kilometer, Bathing or dressing). The scores on the physical functioning domain scale refer 
to the level of which the participant's perceptions of their QOL are affected by their 
physical state. The mean score of physical domain was (70.83%). 
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Table (4.4) Distribution of responses in reference to physical function-related item 
"Physical Function domain" 
SF-36 Domain Yes, limited a 
lot 
Yes, limited a 
little 
No, not limited Mean 
Percentage 
No. % No. % No. % 
Vigorous activities, such 
as running, lifting heavy 
objects, or participation 
in strenuous sports 
60 22.6 176 66.4 29 10.9 44.15 
Moderate activities, such 
as moving a table, 
Vacuuming, bowling or 
golfing 
41 15.5 157 59.2 67 25.3 54.91 
Lifting or carrying 
groceries 
31 11.7 105 39.6 129 48.7 68.49 
Climbing several flights 
of stairs 
31 11.7 154 58.1 80 30.2 59.25 
Climbing one flight of 
stairs 
21 7.9 55 20.8 189 71.3 81.7 
Bending, kneeling, or 
stooping 
18 6.8 78 29.4 169 63.8 78.49 
Walking more than 1.5 
Km 
19 7.2 163 61.5 83 31.3 62.08 
Walking for 1.5 Km 18 6.8 84 31.7 163 61.5 77.36 
Walking for 100 M 17 6.4 50 18.9 198 74.7 84.15 
Bathing or dressing 
yourself 
8 3 20 7.5 237 89.4 93.21 
Mean Physical Function domain  70.38 
Obviously as finding in Table (4.4), indicated that significant portion of participants 
(22.6%) reported limited a lot to perform activities that required physical stamina and 
capacity (Vigorous activities, such as running, lifting heavy objects, or participation in 
strenuous sports). Furthermore, the highest percentage of the study sample reported limited 
a little to perform activities that required physical stamina and capacity (moderate 
activities, lifting or carrying, climbing several flights of stairs, walking for 1.5 km), and the 
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lowest percentages of the study sample were limited a lot to perform activities that required 
physical stamina and capacity (Bathing or dressing yourself).  
Greater severity of visual field abnormality was associated with significantly greater odds 
of disability with vision-related function and physical function (Qiu et al., 2014). 
Moreover, when walking becomes difficult or is accompanied by fear of falling, patients 
may restrict their physical activity (Deshpande et al., 2008), producing decreased quality of 
life (Garatachea et al., 2009). 
Cypel et al., (2004) found that Patients with glaucoma had significantly lower scores than 
healthy control subjects in five domains of the SF-36 (physical functioning, social 
functioning, role-emotional, mental health, and bodily pain). 
Our Finding were consistent to (Lin et al., 2010) that found the mean score of physical 
Function domain was (74.32%), and similar to (Evans et al., 2009) that found the mean 
score of physical Function domain was (70.6). Also, the Finding of our study were 
consistent to (Wändell et al., 1997) who conducted a study to assess the QOL among 
patients with glaucoma in Sweden that found the mean score of physical Function domain 
was (75.0%). 
On the other side, result of our study inconsistent with (Jain et al. 2015) that‘s conduct 
study to assess quality of life of glaucoma patients per WHOQOL-brief found the mean 
score of physical Function domain was (48.75%), also, results disagreed with (Abu-
Muammar, 2014) who conducted a study to assess the QOL among thalassemia patient by 
using SF-36 questionnaire that found the mean score of physical domain was (50.62) and 
(Luzon, 2008) who conducted a study to assess the QOL among stroke patient by using 
SF-36 questionnaire that found it (40.89). 
Our result explains that Glaucoma is a disease that affects the eye and does not affect the 
body completely so the mean of physical function high score compared to other studies. 
4.4.4 Glaucoma and role limitation due to physical health 
The Role limitation due to physical health domain components are (problems with 
participant performance in work or other regular daily activities because of their physical 
health). For example, Reduce the length of time they spent on work or other activities, 
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accomplished less than they would like and Have difficulty performing the work or other 
activities. 
Table (4.5) Distribution of responses in reference to role limitation1 due to physical 
health related item "Role Limitation-Physical domain 
 Yes No Total Mean 
Percentage No. % No. % No. % 
Cut down the length of 
time you spent on work 
or other activities 
191 72.1 74 27.9 265 100.0 27.92 
Accomplished less than 
you would like 
134 50.6 131 49.4 265 100.0 49.43 
Were limited in the kind 
of work or other 
activities 
74 27.9 191 72.1 265 100.0 72.08 
Had difficulty 
performing the work or 
other activities 
70 26.4 195 73.6 265 100.0 73.58 
Mean of Role limitation due to physical health 55.75 
Obviously as finding in Table (4.4), indicated that (72.1%) had reported limited role due to 
their physical health, this limited was for (Reduce the length of time they spent on work or 
other activities). Only (26.4%) reported that they had difficulties in performing the work or 
other activities. 
That means the higher percentage of the study sample have good physical health 
functioning that enables them to perform these activities like work or other daily activities 
without any problem. The mean score of role limitation due to the physical health domain 
was (55.75%). 
Our findings were consistent to Lin et al., (2010) that found the mean score of role 
limitation due to physical health domain was (57.79), Also, the Finding of our study were 
consistent to Wändell et al., (1997) that found the mean score of Role limitation due to 
physical health domain was (49.5%), and inconsistent Evans et al., (2009) that found that 
the mean score of role limitation due to physical health domain was (66.4).  
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Our results disagreed as well, with (Abu-Muammar, 2014) who conducted a study to 
assess the QOL among thalassemia patient by using SF-36 questionnaire that found the 
mean score of role limitation due to physical health domain was (24.68) and (Luzon, 2008) 
who conducted a study to assess the QOL among stroke patient by using SF-36 
questionnaire that found it (28.05). 
4.4.5 Glaucoma and role limitation due to emotional problems 
The Role limitation due to emotional problems domain components are (problems with 
participant performance in work or other regular daily activities because of their emotional 
problems). For example, Reduce the length of time they spent on work or other activities, 
accomplished less than they would like and Didn't do work or other activities as carefully 
as usual.  
Table (4.6) Distribution of responses in reference to role limitation due to emotional 
problem related item "Role Limitation-Emotional domain 
 Yes No Total Mean 
Percentage No. % No. % No. % 
Cut down the length of 
time you spent on work 
or other activities 
174 65.7 91 34.3 265 100.0 34.34 
Accomplished less than 
you would like 
93 35.1 172 64.9 265 100.0 64.91 
Didn't do work or other 
activities as carefully as 
usual 
65 24.5 200 75.5 265 100.0 75.47 
Mean of Role limitation due to Emotional problems 58.24 
As shown in Table (4.6) A great portion of participant (65.7%) reported limited role due to 
their emotional problems, this limited was for (Reduce the length of time they spent on 
work or other activities). On the other hand, (24.5%) reported that they Didn't do work or 
other activities as carefully as usual. That mean they had problems with work or other daily 
living activities because of emotional problems that directed to role limitation. The mean 
score of role limitation due to emotional problems domain was (58.24%).  
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Cypel et al., (2004) found that Patients with glaucoma had significantly lower scores than 
healthy control subjects in five domains of the SF-36 (physical functioning, social 
functioning, role-emotional, mental health, and bodily pain). 
Our Finding were consistent to Wändell et al., (1997) that found the mean score of Role 
limitation due to Emotional problems domain was (57.3%). 
Also, our results were consistent to Lin et al., (2010) that found the mean score of role 
limitation due to Emotional problems domain was (64.08), and inconsistent with Evans et 
al., (2009) that found the mean score of role limitation due to Emotional problems domain 
was (69.80). 
Our study explained why the low mean of Role limitation due to Emotional problems, this 
could be due to the expect the glaucoma diagnosis and its consequences on visual function 
to affect a patient emotionally. 
Our findings were inconsistent with (Abu-Muammar, 2014) who conducted a study to 
assess the QOL among thalassemia patient by using SF-36 questionnaire that found the 
mean score of role limitation due to Emotional problems domain was (31.88) and (Luzon, 
2008) who conducted a study to assess the QOL among stroke patient by using SF-36 
questionnaire that found it (42.97). 
4.4.6 Glaucoma and vitality  
The vitality domain components are (what extent the participants are feeling active and full 
of pep, or worn out and tired). The mean score of vitality domain was (54.09%), which 
concerned the second lowest QOL score. 
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Table (4.7) Distribution of responses in reference to vitality related item "Vitality 
domain 
  
All of the 
time 
Most of 
the 
time 
A good 
bit of 
the 
time 
Some 
of the 
time 
A little 
of the 
time 
None 
of the 
time 
Mean 
Perce
ntage 
Feel full of life No. 17 32 74 59 68 15 53.13 
% (6.4%) (12.1%) (27.9%) (22.3%) (25.7%) (5.7%) 
Have a lot of 
energy 
No. 2 57 62 47 89 5 53.06 
% (1.9%) (21.5%) (23.4%) (17.7%) (33.6%) (1.9%) 
Feel worn out No. 5 57 62 47 89 5 56.6 
% (1.9%) (21.5%) (23.4%) (17.7%) (33.6%) (1.9%) 
Feel tired No. 12 71 56 26 51 49 53.58 
% (4.5%) (26.8%) (21.1%) (9.8%) (19.2%) (18.5%) 
Mean of Energy/ Fatigue 54.09 
Results listed in Table (4.7) indicated that (6.4%) of the participant reported that they felt 
full of life all the time, (23.4%) have a lot of energy at a bit of the time. 
On the other hand, (33.6%) of participant reported that they felt worn out a little of the 
time and (26.8%) felt tired most of time. 
From a systematic review of studies that used the SF-36 survey to evaluate QOL in 
glaucoma patients, reported that vitality was the most affected domain. 
Our findings were similar to Lin et al., (2010) that found the mean score vitality domain 
was (54.71), and consistent with Evans et al., (2009) that found the mean score of vitality 
domain was (57.8). 
Moreover, Results of our study were inconsistent with (Abu-Muammar, 2014) who 
conducted a study to assess the QOL among thalassemia patient by using SF-36 
questionnaire that found the mean score of vitality domain was (32.70) and Disagree with 
(Luzon, 2008) who conducted a study to assess the QOL among stroke patient by using 
SF-36 questionnaire that found the mean score of vitality domain was (71.6). 
Our study clarifies the low score of vitality (energy) among glaucoma patients because 
most of the glaucoma patient in the sample above the 40 years (elderly) and usually 
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decreases activity of individuals in this stage and the weakness of the vital functions of the 
body. 
4.4.7 Glaucoma and Mental Health (Emotional wellbeing) 
The Mental Health domain components are (what extent of the participants are feeling 
nervous, downhearted and blue and feeling calm and peaceful also a happy person). The 
mean score of Mental Health domain was (54.70%), which concerned the third lowest 
QOL score. 
Table (4.8) Distribution of responses in reference to mental health related item 
"Mental Health domain 
  
All of 
the 
time 
Most of 
the 
time 
A good 
bit of 
the 
time 
Some 
of the 
time 
A little 
of the 
time 
None 
of the 
time 
Mean 
Perce
ntage 
Have been a very 
nervous person 
No. 15 94 64 15 26 51 
47.25 
% (5.7%) (35.5%) (24.2%) (5.7%) (9.8%) (19.2%) 
Have felt so down in 
the dumps that 
nothing could cheer 
you up 
No. 8 89 40 23 29 76 
55.4 
% (3.0%) (33.6%) (15.1%) (8.7%) (10.9%) (28.7%) 
Have felt calm and 
peaceful 
No. 1 21 98 54 84 7 
56.6 
% (0.4%) (7.9%) (37.0%) (20.4%) (31.7%) (2.6%) 
Have felt 
downhearted and 
blue 
No. 7 79 47 19 40 73 
56.98 
% (2.6%) (29.8%) (17.7%) (7.2%) (15.1%) (27.5%) 
Have you been a 
happy person 
No. 1 47 62 53 81 21 
57.28 
% (0.4%) (17.7%) (23.4%) (20.0%) (30.6%) (7.9%) 
Mean of Emotional Well being 54.70 
Results listed in Table (4.8) indicated that (35.5%) of the participant reported felt nervous, 
(29.8%) felt downhearted and blue. Results also indicated that (33.6%) felt so down in the 
dump that nothing could cheer you up most of the time. 
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Nevertheless, a significant portion of participant (23.4%) reported that they felt happy and 
(37.0%) reported clam in a good bit of the time. 
Our study noted that some people with glaucoma feel happy and adapted with the disease, 
this is due to the belief that is predestined from Allah and they're so full of satisfaction. 
Patients with glaucoma have lower scores in functional status and Emotional Wellbeing, 
than patients without glaucoma as tested by the SF-36 questionnaire (Wilson et al., 1998). 
The level of understanding about glaucoma is an independent factor negatively associated 
with psychological disturbance and positively associated with QOL in patients with 
glaucoma. On the other hand, it is a subjective factor which can be controlled, so informing 
knowledge about glaucoma and establishing appropriate habits might help patients 
alleviate psychological disturbance and enhance their QOL. (Kong et al., 2014). More than 
80% reported negative emotions on learning that they had glaucoma, one-third were afraid 
of going blind. (Odberg et al. 2001). 
The prevalence of anxiety and depression in patients with POAG was assessed on a case–
control study conducted by Mabuchi et al., (2008), using the Hospital Anxiety and 
Depression Scale (HADS) questionnaire found that the prevalence of patients with anxiety 
(13.0%) and depression (10.9%) was significantly higher than in the control group. 
Moreover, Glaucoma Anxiety group in QOL study the answer were: 54% worried about 
their intraocular pressure, 58% think about a surgical intervention, 66% have insomnia, 
74% are concerning about blinding (Bogdanici et al. 2010). 
Jung et al. (2016) conduct study to assess Mental Health Status and Quality of Life in 
Undiagnosed Glaucoma Patients reported that symptoms of "some or severe problems" in 
all 5 dimensions of the EuroQoL-5 instrument, including anxiety/depression, was higher in 
the glaucoma group than in the nonglaucoma group. 
Also, Glaucoma negatively affects psychosocial functioning. Early stage glaucoma with 
mild visual filed loss adversely affects anxiety, self-image, and confidence in health care. 
As Visual acuity worsens in advanced glaucoma, anxiety further increases and self-image 
deteriorates. Ophthalmologists and glaucoma patients need to be aware that both Visual 
acuity and visual filed losses at different stages of glaucoma negatively impact 
psychosocial functioning. (Chan et al. 2015)  
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Our findings were consistent to (Lin et al., 2010) that found the mean score of Emotional 
Wellbeing domain was (65.32), and inconsistent with (Evans et al., 2009) that found the 
mean score of Emotional Wellbeing domain was (72.9). 
Moreover, result of our study consistent with (Jain et al. 2015) that‘s conduct study to 
assess quality of life of glaucoma patients per WHOQOL found the mean score of 
psychological domain was (49.70%). 
Our results were inconsistent with (Abu-Muammar, 2014) who conducted a study to assess 
the QOL among thalassemia patient by using SF-36 questionnaire that found the mean 
score of Emotional Wellbeing domain was (33.19) and (Luzon, 2008) who conducted a 
study to assess the QOL among stroke patient by using SF-36 questionnaire that found it 
(81.28). 
Tastan et al. (2010) reported that the incidence of depression and anxiety increased with 
decreasing quality of life scores. Quality of life was associated negatively with anxiety and 
depression in patients with glaucoma. However, the QOL indices were notably reduced in 
glaucomatous patients without visual field defects, which was due to a changed 
psychological status. (Illarionova et al. 2002). 
Our study explained the low QOL in mental health domain (Emotional Wellbeing) among 
Glaucoma patients due to the fearing of the blindness that's what makes them nervous, 
worried, frustrated most of the time. 
4.4.8 Glaucoma and social functioning 
The social functioning domain components are (social activities and interaction with 
others, such as family members, friends, neighbors and other social relations.). The mean 
score of social functioning domain was (77.22%). 
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Table (4.9) Distribution of responses in reference to social function related item 
"Social Function domain 
  Not at 
all 
l Slightly Moder
ately 
Quite 
a bit 
Extre
mely 
Mean 
Percentage 
Physical health or 
emotional problems 
interfered with your 
normal social 
activities with family, 
friends, neighbors or 
groups  
No. 120 30 86 16 13 
71.5 
% (45.3%) (11.3%) (32.5%) (6.0%) (4.9%) 
 
 
All of 
time 
Most of 
time 
Some of 
time 
A little 
of Time 
None of 
Time 
Mean 
Physical health or 
emotional problems 
interfered with your 
social activities (like 
visiting friends, 
relatives) 
No. 11 12 96 15 131 
72.9 
% (4.2%) (4.5%) (36.2%) (5.7%) (49.4%) 
Mean of Social Function domain 77.22 
Regarding the social function, data suggest that (49.4%) of the participants as a show in the 
Table (4.9), reported that they didn't have any interfered with social activity.  Only (9.1%) 
of the participants reported that they have interfered with social activity. It's not surprising 
for this domain to elicit high score. A possible explanation for the high QOL in social 
function among Glaucoma patients due to that the Palestinian people, have close social 
inter-relationship between them and family, friends, neighbors or groups, and visiting 
friends and relatives. 
Visually impaired people are at higher risk than the healthy population for accidents, social 
isolation, and depression (McGwin et al.2005; Ribeiro et al., 2015).  A strong correlation 
between decreasing visual acuity, visual filed and QOL scores with greatest impact on 
social and mobility-related activities (Tran HM et al. 2011). 
Our Finding were consistent to (Wändell et al., 1997) that found the mean score of Social 
Function domain was (86.8%). Nordmann et al., (2003) who conducted a study to assess 
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Vision related quality of life and topical glaucoma treatment side effects using NEI-VFQ-
25 global score found that the mean score general health of domain was (85.5). 
Results of our study were consistent to (Evans et al., 2009) that found the mean score of 
Social Function domain was (80.9), and like with (Lin et al., 2010) that found the mean 
score of Social Function was (78.64).  In contrast, result inconsistent with Jain et al. (2015) 
who conduct study to assess quality of life of glaucoma patients per WHOQOL-brief found 
the mean score of Social Function was (47.41%). 
For local studies, Results of our study were inconsistent with (Abu-Muammar, 2014) who 
conducted a study to assess the QOL among thalassemia patient by using SF-36 
questionnaire that found the mean score of Social Function domain was (51.78) and 
Results were consistent to (Luzon, 2008) who conducted a study to assess the QOL among 
stroke patient by using SF-36 questionnaire that found it (71.39). 
4.4.9 Glaucoma and bodily pain 
The bodily pain domain components are (what extent the participant's experience of bodily 
pain reduces their performance of daily activities, involving work-related duties in the 
public environment and tasks within the home). The mean score of bodily pain domain was 
(79.42%), which concerned the best QOL score. 
Table (4.10) Distribution of responses in reference to bodily pain related item "Bodily 
Pain domain 
  
None 
Very 
Limit 
Mild 
Moder
ately 
Sever 
Very 
Sever 
Mean 
Percentage 
How much 
physical pain 
have you had 
during the past 4 
weeks?  
 
No. 178 15 5 36 15 16 
79.40 
% (67.2%) (5.7%) (1.9%) (13.6%) (5.7%) (6.0%) 
 
 Not at all l Slightly 
Moderate
ly 
Quite a 
bit 
Extremel
y 
Mean 
How much did pain 
interfere with your 
normal work?  
 
No. 186 12 11 40 16 
79.43 
% (70.2%) (4.5%) (4.2%) (15.1%) (6.0%) 
Mean of Bodily Pain domain 79.42 
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Results listed in Table (4.10) indicated that (67.2%) of the participant reported that they 
don't have bodily pain and (70.2%)of them were no contradiction between physical pain 
and perform works both inside and outside the home. 
On the other hand, the same data indicated that (6%) of participant reported that they have 
extremely body pain.  
Our findings were consistent to Lin et al., (2010) that found the mean score of bodily pain 
domain was (73.04), and inconsistent with Evans et al., (2009) that found the mean score 
of bodily pain domain was (72.7). Also, our Finding were consistent to Wändell et al., 
(1997) that found the mean score of bodily pain domain was (71.2%)  
For local studies, Results of our study were inconsistent with (Abu-Muammar, 2014) who 
conducted a study to assess the QOL among thalassemia patient by using SF-36 
questionnaire that found the mean score of bodily pain domain was (49.90) and the results 
were consistent with (Luzon, 2008) who conducted a study to assess the QOL among 
stroke patient by using SF-36 questionnaire that found it (76.24). 
4.4.10 Health compared to one year earlier 
Table (4.11) Distribution of responses in reference to health compared to one year 
earlier 
  Much 
better 
now 
 
Some
what 
better 
now 
About 
the 
same 
 
Some
what 
worse 
now 
Much 
worse 
now 
 
Total 
Health compared 
to one year earlier 
No. 4 26 107 118 10 265 
% (1.5%) (9.8%) (40.4%) (44.5%) (3.8%) (100.0%) 
As show in the Table (4.11) the patients assessment of their health in comparison to one 
year earlier. About half of the study sample (44.5%) evaluated personal health as worse 
compared to one year earlier.  
Our study explains the high worse in the health than the previous year due to the disease is 
progressive over time and the lack of follow-up, adherence to treatment also health 
problems that associated with elderly, which worsens the QOL level. 
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4.5 Quality of Life Domain (Glaucoma Quality of Life-15 Questionnaire) 
QOL consists of four core domains, including 15 items. The results from the analysis of 
the GQL-15 questionnaire were divided into four domains. These include: central vision, 
peripheral vision, outdoor mobility, Glare and dark adaptation. 
The Table (4.12) shows that the mean score for the GQL-15 subscales ranged from 
(66.6%) for Outdoor mobility to (48.5%) for Glare and dark adaptation. 
Table (4.12) Scores obtained in the GQL-15 from patients Glaucoma disease (n=265)   
 
GQL-15 Domains 
No. of 
Items 
Mean SD 
Central vision 2 57.3 19.1 
Peripheral vision 6 61.4 19.4 
Outdoor mobility 1 66.6 25.4 
Glare and dark adaptation 6 48.5 18.0 
Total GQL-15 domains 15 59.2 17.6 
The results showed that the highest domain was outdoor mobility with a mean of (66.6%), 
and the lowest domain score was Glare and dark adaptation with a mean of (48.5%). The 
researcher found that glaucoma mainly affected the central vision of patients. Additionally, 
the results revealed that a mean score of Peripheral vision domain was (61.4%).  
The summary score was 59.2 (SD ± 17.6) in glaucoma patients and Subscale score showed 
that dark adaptation and glare was problematic to majority in assessing Quality of Life in 
patients with Glaucoma using the Glaucoma Quality of Life-15 questionnaire in Indian 
eyes (Naveen et al. 2014). And this consistent with our study results. Onakoya et al. (2012) 
conduct study to Assessing Quality of life of primary open angle glaucoma patients in 
Nigeria, reported that, the mean score was 75.93 (SD ± 12.4).  
Moreover, Zhou et al., (2014) conduct a study to assessing Quality of life of glaucoma 
patients in China: sociodemographic, clinical, and psychological correlates, a cross-
sectional study using the Glaucoma Quality of Life-15 (GQL-15) questionnaire reported 
that, the mean score was 71.21(SD ± 12.74). 
Also, Goldberg et al (2009) conduct a study to Assessing quality of life in patients with 
glaucoma in Australia using the Glaucoma Quality of Life-15 (GQL-15) questionnaire 
reported that reported that, the mean score was 69.5(SD ± 13.7). 
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 In our study, tasks involving Glare and dark adaptation are most affected in POAG 
patients 
 Goldberg et al (2009), Onakoya et al (2012) and Naveen et al. (2014) also reported 
glare and dark adaptation to be most affected in glaucoma patients 
Palestinian glaucoma patients had a moderate VRQOL level when compared to the results 
from other countries. 
Potential explanations for these differences may lie in several aspects. First, the sample 
sizes differed greatly (China, 508; Nigeria, 132; Australia, 121), however, a small sample 
size may not capture the full variety of glaucoma patients and cause a deviation.  
Moreover, The Nigerian study included patients with POAG at least 40 years old and the 
Australian patients were also with POAG but at least 44 years old. Our study covered the 
same varieties of glaucoma, but with a more evenly distributed sample size of each 
glaucoma type and a broader age above 18 years. The divergences of these researched may 
result from the cultural and social variances, different QOL assessing instruments, and 
varied independent variables included in the studies. 
4.5.1 Effect of Glaucoma on central vision 
This dimension assesses the extent to which the central vision of the participant, e.g. 
Newspaper reading, recognizing faces were affected by glaucoma. The mean score of 
central vision domain was (57.27%). 
Table (4.13) Distribution of responses in reference to Central Vision 
   
None 
Difficulty 
Mild 
Difficulty 
Moderately 
Difficulty 
Sever 
Difficulty 
Very 
Sever 
Difficulty 
Mean 
Percentage 
Newspaper 
reading 
No. 16 42 122 59 5 
50.51 
% (6.6%) (17.2%) (50.0%) (24.2%) (2.0%) 
Recognizing 
faces 
No. 41 85 111 26 2 
62.92 
% (15.5%) (32.1%) (41.9%) (9.8%) (0.8%) 
 Mean of Central Vision 57.27 
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Results listed in Table (4.10) indicated that (50%) of the participant reported that they had 
moderately difficulty in reading, while (41.9%) had the same degree of difficulty in 
Recognizing faces. On the other hand, (15.5%) of the participant reported no difficulty in 
recognizing faces. Only (6.6%) reported no difficulty in Newspaper reading. 
Difficulty with central and near vision tasks in general, and with reading specifically, are 
the most frequent complaint among subjects with eye disease. Near vision tasks such as 
reading are also the most valued visual function among a patient with glaucoma (Burr et 
al. 2007).  Central VF and visual acuity are generally spared until the disease is more 
advanced. Patients with binocular VF loss have serious difficulties in activities of daily life 
such as reading, mobility, or driving (Friedman et al. 2007). 
In the SEE study, patients with bilateral Glaucoma were almost 5 times more likely to 
report severe difficulty with near activities than patients without Glaucoma (Freeman et al. 
2008). Difficulties with central and near vision tasks in general, and with reading 
specifically, are the most common complaint among people with eye disease. Near vision 
tasks for example, readings are also the most valued visual function in those with 
glaucoma. While reading is clearly dependent on visual acuity, complaints of difficulty 
reading are commonplace and were noted in over 40% of the glaucoma patients (Ramulu et 
al. 2009). 
Bogdanici et al. (2010) who conduct a study to assess Quality of life in glaucoma patients, 
and Glaucoma patients divided into three groups and found the second group: 68% can't 
read a small letter, 70% can't recognize the people and varied things afoot, 66% need more 
time to do simple tasks, 76% can't manage in an unfamiliar environment, 36% fill that they 
find more help among people. 
Our study explains this decline because of that most of the study sample over 40 years and 
therefore, most of them have presbyopia with affected on the reading and in addition many 
of them have other ocular diseases and refractive errors with affected on the reading and 
Recognizing faces. Other possible explains: Palestinian people do not have a reading 
culture and for that, reason may not accurately respond to QOL questions regarding 
difficulties encountered when reading newspapers, books.   
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4.5.2 Effect of Glaucoma on Peripheral vision 
This dimension attribute to the extent to which the Peripheral vision of the participant, e.g. 
Tripping over the object, seeing objects come from the side, walking in steps/ stairs and Bumping 
into objects were affected by glaucoma. 
Table (4.14) Distribution of responses in reference to peripheral vision 
  
None 
Difficulty 
Mild 
Difficulty 
Moderately 
Difficulty 
Sever 
Difficulty 
Very 
Sever 
Difficulty 
Mean 
Percent
age 
Walking in uneven 
ground 
No. 37 119 96 9 4 
66.6 
% (14.0%) (44.9%) (36.2%) (3.4%) (1.5%) 
Tripping over object No. 32 41 131 52 9 
53.3 
% (12.1%) (15.5%) (49.4%) (19.6%) (3.4%) 
Seeing objects come 
from the side 
No. 36 57 147 23 2 
59.62 
% (13.6%) (21.5%) (55.5%) (8.7%) (0.8%) 
Walking in steps/ 
stairs 
No. 68 103 79 11 4 
70.72 
% (25.7%) (38.9%) (29.8%) (4.2%) (1.5%) 
Bumping into objects No. 33 44 132 49 7 
54.43 
% (12.5%) (16.6%) (49.8%) (18.5%) (2.6%) 
Judging distance of 
foot to step / curb 
No. 45 73 133 13 1 
63.96 
% (17.0%) (27.5%) (50.2) (4.9%) (0.4%) 
Mean of peripheral vision 61.45 
As shown in Table (4.14), Roughly a bit higher than half of participants reported that they had 
moderately difficulty in seeing objects come from the side, while (49.4%,49.8) had the same degree 
of difficulty in tripping over object and bumping into objects. Moreover (4.2%) had severe 
difficulty in walking in steps/ stairs. 
In contrast, a significant portion of participant (25%) reported no difficulty in walking in 
steps/ stairs. Also, approximately (12%) reported no difficulty with tripping over object 
and bumping into objects. The mean score of Peripheral vision domain was (61.45%).  
Glaucoma and AMD patients with similar visual acuity experienced similar overall 
impairment in QOL. However, glaucoma patients described more difficulty with peripheral 
vision and ocular pain, whereas AMD patients complained more about near and distance 
vision and dependency items (Ugurlu et al., 2016). 
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Nelson et al., (1999) conducted a study about Patients‘ perception of visual impairment in 
glaucoma reported that glaucoma patients also had problems with vision in activities 
demanding functional peripheral vision. Bilateral VF loss resulting from glaucoma is 
associated with greater fear of falling (Ramulu et al., 2012). 
Restriction of travel outside the home in individuals with glaucomatous VF loss is 
consistent with prior research demonstrating a broad range of mobility deficits in 
individuals with VF loss, including worse balance, more bumping into objects, driving 
restriction, falls, fear of falling, decreased physical activity and greater self-reported 
mobility difficulty. (Nguyen et al., 2015; Labiris et al., 2010; Aspinall et al., 2008). 
It is exciting to note that peripheral vision which is the first area of the visual field affected 
in glaucoma was not the worst score. 
Viswanathan et al., (1999) demonstrated that two of the strongest correlates with binocular 
VF loss were difficulty with stairs and bumping into objects, these abilities appear to be 
linearly and progressively affected in the progression of the disease, influencing QOL 
more in advanced stages. This consistent with several studies (Mangione et al., 2001; 
Labiris et al., 2010; Wu et al., 2008). 
Our study explains this decline because of the visual filed affected by glaucoma and 
therefore, the patient does not see things around them and from the side clearly, so a lot of 
them bumping objects and Tripping over the object. 
4.5.3 Effect of Glaucoma on Outdoor mobility 
This dimension points to the extent to which the Outdoor mobility of the participant, e.g. 
Crossing the road was affected by glaucoma. The mean score of outdoor mobility domain 
was (66.60%). 
Table (4.15) Distribution of responses in reference to Outdoor mobility 
  None 
Difficulty 
Mild 
Difficulty 
Moderately 
Difficulty 
Sever 
Difficulty 
Very Sever 
Difficulty 
Mean 
Percent
age 
Crossing the 
road 
No. 67 77 91 25 5 66.60 
% (25.3%) (29.1%) (34.3%) (9.4%) (1.9%) 
 Mean of Outdoor Morbidity 66.60 
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As shown in Table (4.15), A significant portion of participants (34.3%) reported moderate 
difficulty in crossing the road, while (9.4%) reported severe difficulty in crossing the road. 
In contrast, (25.3%) reported that they don‘t have any difficulty in crossing the road.   
Current study explained that due to the level of visual impairment in the mild glaucoma 
had not started to affect their ability to function as outdoors. 
Difficulty with walking was the most common complaint for glaucoma patients after 
difficulty with lighting, 49% describing difficulties with steps, 42% describing difficulty 
going shopping, and 36% describing difficulty crossing the road (Nelson et al., 1999). 
Bilateral vision impairment in this population was associated with substantial decrements 
in mobility and independence, with glaucoma and cataract independently associated with 
worse mobility and independence. (Fenwick et al. 2016). 
Our study explains this due to the affected visual filed resulting from glaucoma, which 
restricts the movement of the patient and makes them find it very difficult to cut the road.  
Tran HM et al. (2011) reported a strong correlation between decreasing visual acuity, 
visual filed and QOL scores with the greatest impact on social and mobility-related 
activities. 
4.5.4 Effect of Glaucoma on Glare and dark adaptation 
This dimension points about the extent to which the Glare and dark adaptation of the 
participant, e.g. walking after dark, seeing at night, adjusting to bright lights and findings 
dropped objects were affected by glaucoma. The mean score of glare and dark adaptation 
domain was (48.47%), which concerned the lowest QOL score. 
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Table (4.16) Distribution of responses in reference to Glare and dark adaptation 
  
None 
Difficulty 
Mild 
Difficulty 
Moderately 
Difficulty 
Sever 
Difficulty 
Very 
Sever 
Difficulty 
Mean 
Percentage 
Walking after 
dark 
No. 24 49 148 40 4 
54.62 
% (9.1%) (18.5%) (55.8%) (15.1%) (1.5%) 
Seeing at night No. 20 55 160 25 5 
55.66 
% (7.5%) (20.8%) (60.4%) (9.4%) (1.9%) 
Adjusting to 
bright lights 
No. 4 12 80 126 43 
31.89 
% (1.5%) (4.5%) (30.2%) (47.5%) (16.2%) 
Adjusting to dim 
lights 
No. 9 49 123 70 14 
47.08 
% (3.4%) (18.5%) (46.4%) (26.4%) (5.3%) 
Going from light 
to dark room or 
vice versa 
No. 13 55 142 51 4 
52.08 
% (4.9%) (20.8%) (53.6%) (19.2%) (1.5%) 
Findings dropped 
object's 
No. 41 48 73 71 32 
49.53 
% (15.5%) (18.1%) (27.5%) (26.8%) (12.1%) 
 Mean of Glare and dark adaptation 48.47 
Results listed in Table (4.16) indicated that (60.4%) of the participant reported that they 
had moderately difficulty in seeing at night, while (55.8%) had the same degree of 
difficulty walking after dark. Moreover (47.5%) had severe difficulty in Adjusting to bright 
lights. On the other hand, (9.1%) of the participant reported no difficulty at Walking after 
dark. 
The concern of dark adaptation in glaucoma was addressed by Glovinsky et al. (1992) who 
found abnormal scotopic sensitivity in glaucoma patients when compared to normal. 
Glaucoma patients have difficulties related to lighting, such as glare, and difficulty 
adapting to different levels of light (Nelson et al., 1999). Mangione et al. (1998) reported 
that 82% of glaucoma subjects had difficulty seeing in the dark compared to 32% of 
controls. 
The three most problematic activities affecting quality of life in open-angle glaucoma 
patients were "adjusting to bright lights", "going from a light to a dark room or vice versa", 
and "seeing at night" (Lee et al., 2014). 
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 At Initial diagnosis for newly diagnosed glaucoma patients, difficulty with bright lights 
and difficulties with light and dark adaptation were the most frequently reported symptoms 
related to visual function, whereas visual distortion was the most annoying (Janz et al., 
2001). 
Our study explains this decline because of the glaucoma affected peripheral vision which 
equal the outer area of the retina that have more rods (Responsible for vision at night and 
adjust to the dim light), so loss of peripheral vision often resulting 
insufficient adaptation to darkness and seeing at night. 
Our findings consistent with ((Nelson et al., 2003; Goldberg et al., 2009; Viswanathan et 
al., 1999; Skalicky & Goldberg 2008; Burr et al.,2007; Zhou et al., 2014) that glare and 
dark adaption is the most affected domain in glaucoma patients. 
4.6 Inferential Analysis  
To explore differences in perceptions of the QOL about health-related variables and 
demographic and socioeconomic characteristic's variables, the researcher conducted 
inferential analysis as clarified below. 
4.6.1 QOL and Gender 
4.6.1.1 Differences in perceptions about QOL (SF – 36) according to gender 
Table (4.17) Illustrated that gender and QOL positively associated. Results show that, male 
patients had better QOL than female on all subscales (physical functioning, physical role, 
general health, vitality, mental health, social functioning, Pain, and emotional role) and on 
both summary scales PCS and MCS. 
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Table (4.17) Differences in perceptions about QOL (SF – 36) per gender 
 Male n (147) Female n (118) t test Sig. 
Mean SD Mean SD 
Physical Function 74.0 20.8 65.9 26.3 2.798 0.006 
Role limitation due to physical 
Health 
56.0 29.5 55.5 24.7 0.131 0.896 
Role limitation due to 
emotional problems  
62.8 32.8 52.5 30.6 2.610 0.010 
Energy / Fatigue  54.3 10.7 53.9 9.1 0.285 0.776 
Emotional well being 55.7 13.5 53.4 12.7 1.421 0.157 
Social Functioning 78.1 25.3 64.9 31.1 3.784 0.000 
Pain 85.6 29.1 71.7 36.7 3.457 0.001 
General Health 49.3 9.3 47.7 7.9 1.464 0.144 
MCS 70.6 16.6 60.6 19.0 4.522 0.000 
PCS 58.4 11.9 55.8 11.5 1.808 0.072 
Total SF– 36 domains 64.5 12.7 58.2 13.8 3.842 0.000 
According to table (4.17) there are statistical differences between Total SF-36 domains and 
Gender (t = 3.842, Sig =0.000) as indicated by t-test, the differences was in the domains 
"Physical Function, Role limitation due to emotional problems, Social Functioning and 
Pain" the differences was for male with means higher than females. 
For the Physical Function domain, there were statistical significant differences between the 
Glaucoma patients (f=2.798; p=0.006) due to gender, the differences were toward the 
Glaucoma male patients, which means that the male patients have higher scores in the 
Physical Function domain than the female patients. The mean of male patients was 64.5 
while for female was 58.2. 
And for the Social Functioning domain, there were statistical significant differences 
between the Glaucoma patients (f=3.784; P=0.000) due to gender, the differences were 
toward the Glaucoma male patients, which means that the male patients have higher scores 
in the Social Functioning domain than the female patients. 
Females with chronic health conditions had the poorer quality of life in the physical and 
psychological domains as compared to males with chronic health conditions (da Rocha et 
al., 2014), A relatively high prevalence of depression (30%) and anxiety disorders (64%) 
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among glaucoma patients in Singapore. Female glaucoma patients are more likely to suffer 
from depression (Lim et al., 2016). Tastan et al. (2010) reported that the anxiety risk in 
women with glaucoma was found to be 7.5 times higher than in men in Turkish patients 
with glaucoma. Females had increased fear of blindness most of the time, and that fear of 
blindness was significantly more in women than in men (Janz et al. 2007). 
Women with good physical and psychosocial health are more likely to have a better QOL 
(Campos et al. 2014). Woods et al. (2005) described that women depend on feelings of 
discomfort during physical activity in reporting HRQOL as compared to males. 
Our findings were consistent with Tran HM et al., (2011) conducted a population-based 
study in Nigeria reported that the women had worse QOL compared to the men. 
Possible explanation could be that the Female in Palestinian society had the greatest 
responsibility to work both inside and outside the home, raising children and taking care of 
them also do household causes low scores in the QOL results. 
4.6.1.2 Differences in perceptions about QOL (GQL-15) according to gender 
Findings and statistical analysis as Table (4.18) indicate that Females in this study had 
better QOL scores than the male glaucoma patients. Also, it showed that, female patients 
had better QOL than male on three of four subscales (Central vision, Peripheral vision, 
Outdoor mobility), and better of the total QOL domains (60.4).  
Table (4.18) Differences in perceptions about QOL (GQL-15) according to gender 
 Male n (147) Female n (118) t test Sig. 
Mean SD Mean SD 
Central vision  56.9 19.8 59.8 18.2 -0.521 0.603 
Peripheral vision  60.8 19.4 62.3 19.4 -0.632 0.528 
Outdoor mobility  66.2 25.6 67.2 25.3 -0.319 0.75 
Glare and dark adaptation 49.0 18.2 49.9 17.7 0.481 0.631 
Total GQL– 15 domains 58.4 17.9 60.4 17.3 -0.922 0.358 
According to table (4.18) t- test indicate that there are no statistical differences between 
Total GQL– 15 domains and Gender (t = 17.3, Sig = 0.864). 
Our findings consistent with (Dhull, 2015) that found all the domains of GQL-15 were 
affected more in male patients as compared to females except outdoor mobility domain. 
Odberg et al. (2001) reported that the women were more dissatisfied than the men. Also, 
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result consistent with Zuo et al. (2015) that‘s conduct study to assess vision-related quality 
of life (VRQOL) in Chinese's glaucoma patients and explore its sociodemographic, clinical 
and psychological correlates by GQL-15 reported that QOL of female patients better than 
male patients.   
In contrast, result of our study inconsistent with Jain et al. (2015) that‘s conduct study to 
assess quality of life of glaucoma patients per WHOQOL-Brief reported that QOL of male 
better compared to female except in (social domain) female better than male. Moreover, 
inconsistent with (Labiris et al. 2010) described that female glaucoma patients had worse 
QOL (lower NEIVFQ scores) than male patients. 
4.6.2 QOL and Age 
4.6.2.1 Differences in perceptions about QOL (SF – 36) according to Age 
Findings and statistical analysis as Table (4.19) indicate that patients whose age was (18-
30) years had better QOL than patients whose age was (31-40) and above 40 years on five 
of the eight subscales (physical functioning, general health, emotional role, physical role, 
and Pain) 
Table (4.19) Differences in perceptions about QOL (SF – 36) according to Age 
 18 to 30 Yrs. 31 – 40 Yrs. Above 40 Yrs. F test Sig. 
Mean SD Mean SD Mean SD 
Physical Function 88.7 17.9 80.0 11.3 67.2 24.2 11.9 0.000 
Role limitation due to 
physical Health 
58.7 30.7 57.4 28.4 55.2 27.0 0.219 0.803 
Role limitation due to 
emotional problems  
60.9 32.8 46.9 34.9 59.4 31.6 1.897 0.152 
Energy / Fatigue  53.7 10.2 54.6 8.4 54.1 10.2 0.057 0.945 
Emotional well being 53.4 13.2 50.5 11.2 55.4 13.3 1.767 0.173 
Social Functioning 70.7 24.0 75.9 24.3 71.9 29.8 0.269 0.765 
Pain 94.1 15.5 79.8 35.9 77.8 34.1 2.527 0.082 
General Health 50.0 8.0 46.3 8.7 48.7 8.8 1.263 0.284 
MCS 69.8 14.1 63.3 19.9 66.1 18.6 0.769 0.464 
PCS 62.8 10.1 59.6 9.3 56.3 12.0 3.839 0.023 
Total SF– 36 domains 66.3 10.6 61.4 12.0 61.2 13.9 1.46 0.234 
 
 81 
According to table (4.19) ANOVA test indicate that there are no statistical differences 
between Total SF-36 domains and age group (F=1.46, Sig.=0.234), but there are statistical 
differences between Physical Function and age group. 
For the Physical Function domain, there were statistical significant differences between the 
Glaucoma patients (f=11.9; p=0.000) due to age group, the differences were toward the 
Glaucoma patients with age 18-30, which means that the age group (18-30) patients have 
higher scores in the Physical Function domain than the other age group patients. The mean 
of (18-30) age group patients was 88.7 while for (31-40) 80.0 and for (more than 40) 67.2 
Tran HM et al. (2011) and Magacho et al. (2004) reported that younger patients had better 
QOL. Result consistent with Jain et al. (2015) that‘s conduct study to assess quality of life 
of glaucoma patients per WHOQOL-Brief reported that younger patients had better QOL. 
Here, our study clarified that the mean score of QOL among younger patients was higher 
than among older age; the reason is younger patients had early or mild glaucoma and thus 
has better QOL. Also, younger patients may have a higher educational status than older 
patients and therefore, a better understanding of the disease, less fear. Moreover, young 
people in full health and have the power that enables them to perform many tasks. In 
addition, the (elderly) usually decreases activity at this stage and the weakness of the vital 
functions of the body will lead to have a low score in Physical Function domain. 
4.6.2.2 Differences in perceptions about QOL (GQL-15) according to Age 
Findings and statistical analysis as Table (4.20) indicate that  patients at different ages have 
approximately the medium level of GQOL, and patients whose age was (18-30) years had 
better QOL than other patients. 
Table (4.20) Differences in perceptions about QOL (GQL-15) per Age 
 
 
18 to 30 Yrs. 31 – 40 Yrs. Above 40 Yrs. 
F test Sig. 
Mean SD Mean SD Mean SD 
Central vision  55.4 18.8 56.5 16.8 57.6 19.6 0.200 0.855 
Peripheral vision  63.9 15.9 63.0 15.9 61.0 20.2 0.332 0.718 
Outdoor mobility  65.2 24.7 70.4 18.4 66.3 26.3 0.346 0.708 
Glare and dark 
adaptation 
51.1 17.6 47.4 14.7 48.3 18.4 0.298 0.743 
Total GQL-15 58.9 15.1 59.3 13.8 58.3 18.5 0.004 0.996 
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According to table (4.20) there are no statistical differences between Total GQL-15 
domains and age group (F = 0.004, Sig = 0.996) as indicated by ANOVA test. 
With population aging, the number of people with visual impairment and blindness is 
rapidly growing, as many eye diseases are more widespread among the elderly. Cataract, 
glaucoma, age-related macular degeneration, and diabetic retinopathy are the most 
common causes of visual impairment (Bourne et al. 2013) 
The main causes of visual impairment were cataracts, refractive error and glaucoma, and 
Visual impairment was found to be associated with advancing age. Also, Quality of life 
was found to be poor in the domains of visual function and social interaction, Quality of 
life was found to be related to the degree of visual impairment (s Oluleye et al. 2014). 
Janz et al. (2001) and Goldberg et al. (2009) reported that the younger glaucoma patients 
have greater vision-related problems than older patients with glaucoma. 
Possible explanation could be: younger patients may have worse QOL and more anxiety 
when they know the diagnosis of glaucoma, and may be worried about the loss of 
opportunities, and incomplete dreams that may be their fate if they lose their vision. 
4.6.3 QOL and Education level 
4.6.3.1 Differences in perceptions about QOL (SF – 36) according to Education level 
Table (4.21) illustrate that the level of education and QOL are positively associated. 
Results show that glaucoma patients when attended more education represented higher 
QOL (mean = 66.8). Also, showed that glaucoma patients at a university level had better 
scores in all QOL domains (physical functioning, physical role, pain, vitality, mental 
health, social functioning, and emotional role) except (general health), and had better 
scores on both summary scales PCS and MCS.  
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Table (4.21) Differences in perceptions about QOL (SF – 36) according to Education 
level 
 Illiteracy Primary Secondary University 
F test Sig. 
Mean SD Mean SD Mean SD Mean SD 
Physical Function 45.2 32.5 70.0 19.5 74.3 21.5 78.7 18.8 16.10 0.000 
Role limitation due to 
physical Health 
48.3 26.7 53.3 25.9 56.8 28.8 63.0 26.7 2.127 0.097 
Role limitation due to 
emotional problems  
46.0 33.8 54.6 30.4 60.3 33.6 68.8 28.5 3.702 0.012 
Energy / Fatigue  52.6 8.9 52.0 9.2 55.1 11.0 57.1 9.0 3.343 0.020 
Emotional well being 50.2 8.3 52.3 13.1 56.9 13.0 57.6 14.6 3.901 0.009 
Social Functioning 49.6 29.8 72.8 27.9 75.9 27.6 77.5 26.4 7.575 0.000 
Pain 60.4 38.3 82.2 30.7 79.6 32.9 85.5 32.8 3.988 0.008 
General Health 46.7 7.8 48.6 8.3 50.0 9.3 46.6 8.3 2.110 0.099 
MCS 51.5 19.6 65.5 15.7 68.2 18.6 72.3 17.6 9.034 0.000 
PCS 48.2 13.9 56.0 9.3 59.1 12.7 61.4 9.2 9.615 0.000 
Total SF– 36 domains 49.9 15.6 60.7 10.8 63.6 14.0 66.8 11.7 11.69 0.000 
According to table (4.21) there are statistical differences between Total SF-36 domains and 
education (F = 11.69, Sig = 0.000) as indicated by ANOVA test, the differences was in the 
domains "Physical Function, Role limitation due to emotional problems, Energy / Fatigue, 
Emotional wellbeing, Social Functioning and Pain". 
For physical function domain, there were statistically significant differences between 
Glaucoma patients (F=16.10; p=0.000) regarding educational level. These differences were 
in favors of the patients at university level, which means that these patients have higher 
scores in the physical function domain than other patients.  
The mean scores of patients at university level were higher than scores of patients at other 
levels, which represented 78.7. In addition, for role limitation due to emotional problems, 
there were statistically significant differences between Glaucoma patients (F=3.702; 
p=0.012) regarding educational level. Once more, these differences were in favors of 
patients at university level, which means that these patients have higher scores in role 
limitation due to emotional problems than in other patients. The mean scores of patients at 
university level were higher than scores of patients at other levels, which represented 
(68.8). 
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Again, these differences were in favors of patients to the university level, which means that 
these patients have higher scores in Energy / Fatigue and Emotional wellbeing, Social 
Functioning and Pain than in other patients. The mean scores of patients at university level 
were higher than scores of patients at other levels, which represented (57.1, 57.6, 77.5, 
85.5) respectively. 
Our study explained that; highly educated patients may have more opportunities as work, 
and financial support, better awareness and understanding about the disease, its 
complications, and how to cope with it. Moreover, they have better accessibility to 
different services and drug availability. This clarifies the importance of education in 
improving better understanding the nature chronic of the disease and its complications, and 
managing with it to have good QOL levels. 
4.6.3.2 Differences in perceptions about QOL(GQL-15) according to Education level 
Table (4.22) illustrate that the level of education and QOL are positively associated. 
Results show that glaucoma patients at a university level had better scores in total QOL 
domains. 
Table (4.22) Differences in perceptions about QOL(GQL-15) per Education level 
 Illiteracy Primary Secondary University 
F test Sig. 
Mean SD Mean SD Mean SD Mean SD 
Central vision  40.3 10.4 55.0 17.6 59.8 18.8 59.5 22.1 3.719 0.012 
Peripheral vision  49.1 16.2 60.4 17.3 64.1 21.3 65.5 18.0 5.554 0.001 
Outdoor mobility  53.5 25.6 68.1 24.7 66.7 26.0 71.7 23.3 3.414 0.018 
Glare and dark 
adaptation 
38.1 14.0 46.9 16.0 49.9 18.5 55.0 20.0 5.998 0.001 
Total GQL-15 
domains 
45.3 9.8 57.7 16.2 60.1 18.5 62.9 18.4 2.924 0.035 
According to table (4.23) ANOVA test indicate that there are statistical differences 
between Total GQL-15 domains and education (F = 2.924, Sig = 0.035), the differences 
was for the participant who had university degree. 
The study confirmed that the greater level of education, the more QOL. Study attribute this 
to culture preference and referred to historical appreciation Palestinian people bears to 
education as a source for security and assurance.  
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Odberg et al. (2001) found that less-educated patients were more afraid of going blind 
from Glaucoma. Also, Omoti et al. (2002) reported that more educated patients presented 
earlier with less visual field defects than less-educated patients. 
Our study explained that; highly educated patients may have more circumstances as work, 
and economic status. Moreover, they have better accessibility to different services and drug 
availability. Additionally, these patients can be understanding the chronic nature of the 
disease and its complications, and how to cope with it. 
A result from our study consistent with Zhou et al. (2014) that‘s conduct study to assess 
vision-related quality of life (VRQOL) in Chinese glaucoma patients and explore its 
sociodemographic, clinical and psychological correlates by GQOL-15 reported that QOL 
of patients with high education was better in all four domains, and consistent with other 
global findings and with local findings.  
4.6.4 QOL and Marital Status 
4.6.4.1 Differences in perceptions about QOL (SF – 36) according to Marital Status 
Findings and statistical analysis as Table (4.23) indicate that married patients had better 
mean scores in five from eight QOL, and single patients had better scores on both 
summary scales PCS and MCS. 
Table (4.23) Differences in perceptions about QOL (SF – 36) according to Marital Status 
 Single Married 
t test Sig. 
Mean SD Mean SD 
Physical Function 75.5 30.0 69.7 22.8 1.259 0.209 
Role limitation due to physical Health 57.5 28.0 55.5 27.4 0.37 0.712 
Role limitation due to emotional 
problems  
61.1 32.9 57.9 32.1 0.518 0.605 
Energy / Fatigue  52.2 9.5 54.3 10.1 -1.12 0.264 
Emotional wellbeing 54.4 12.8 54.7 13.2 -0.133 0.894 
Social Functioning 65.0 29.4 73.1 28.6 -1.463 0.145 
Pain 78.5 31.0 79.5 33.7 -0.159 0.873 
General Health 45.8 7.7 48.9 8.8 -1.845 0.066 
MCS 71.8 14.6 66.3 18.6 1.111 0.268 
PCS 64.1 11.6 57.1 11.6 2.253 0.025 
Total SF– 36 domains 61.3 14.1 61.7 13.5 -0.181 0.857 
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According to table (4.23) t-test indicate that there are no statistical differences between 
Total SF-36 domains and Marital Status (t=-0.181, Sig.=0.857). 
Tran HM et al. (2011) reported that married respondents had better QOL scores than 
unmarried ones and. No reason was given by the researcher for this finding.  
Likewise, Tastan et al. (2010) reported that risk of depression was 2.94 times higher in 
unmarried compared to married participants, and Anxiety scores were higher in unmarried 
participants and women. 
Our study finds that many different studies have shown that marriage really makes people 
healthier and happier and so the quality of life better for them. 
4.6.4.2 Differences in perceptions about QOL(GQL-15) according to Marital Status 
Findings and statistical analysis as Table (4.23) indicate that married patients had slightly 
higher scores in all QOL domains (Central vision, Peripheral vision, Outdoor mobility, 
Glare and dark adaptation). 
Table (4.24) Differences in perceptions about QOL(GQL-15) per Marital Status 
 Single Married 
t test Sig. 
Mean SD Mean SD 
Central vision  56.0 16.6 57.4 19.4 -0.351 0.726 
Peripheral vision  59.7 16.1 61.7 19.8 -0.516 0.606 
Outdoor mobility  59.2 23.2 67.6 25.6 -1.707 0.089 
Glare and dark adaptation 47.9 17.0 48.5 18.1 -0.18 0.857 
Total GQL– 15 domains 56.5 13.6 59.3 18.1 -0.219 0.827 
According to table (4.24) t-test indicate that there are no statistical differences between 
Total GQL-15 domains and Marital Status (t=-0.219, Sig.=0.827).  
 Zuo et al. (2015) conducted a study to assess Vision health-related quality of life in 
Chinese's glaucoma patients reported that VRQOL of married glaucoma patients was 
probably better than that of patients who were unmarried. 
Therefore, provided the high social connection in GGs, Marriage could be seen with these 
relationships rather than a single (by itself) predictor for wellbeing, and this lead to 
increase QOL.   
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4.6.5 QOL and address 
4.6.5.1 Differences in perceptions about QOL (SF – 36) according to address  
Table (4.25) shows the differences in the overall perceptions of QOL per address. Results 
presented that, glaucoma patients who live in Mid-zone have better means of the following 
QOL domains: bodily pain, social function, emotional role limitation and on PCS summary 
scales, and total SF-36 scores than other patients. 
Table (4.25) Differences in perceptions about QOL (SF – 36) according to address 
 North Gaza Mid-zone Khanunis Rafah 
F Sig. 
Mean SD Mean SD Mean SD Mean SD Mean SD 
Physical Function 68.3 21.4 69.4 23.4 74.8 24.1 70.2 28.9 79.7 17.4 0.986 0.415 
Role limitation due to 
physical Health 
57.0 25.3 53.1 28.4 65.0 22.1 54.3 26.8 66.2 30.5 1.575 0.181 
Role limitation due to 
emotional problems  
55.3 29.1 58.2 32.1 68.3 31.5 58.5 34.8 54.9 37.2 0.637 0.636 
Energy / Fatigue  55.5 8.2 53.9 10.5 55.3 6.6 50.5 10.9 58.5 9.6 2.541 0.040 
Emotional well being 55.0 10.2 55.5 13.4 55.4 13.9 52.1 14.9 53.4 13.9 0.568 0.686 
Social Functioning 67.8 30.8 72.5 27.2 80.6 29.4 69.5 32.1 79.4 25.4 1.091 0.361 
Pain 87.8 25.6 77.5 33.9 90.8 20.9 69.6 39.8 80.4 37.5 2.429 0.048 
General Health 47.5 8.3 49.0 8.7 51.5 8.4 46.8 9.1 49.1 8.9 1.274 0.281 
MCS 66.5 17.2 65.9 17.9 73.8 14.7 62.4 21.0 67.0 21.4 1.307 0.268 
PCS 57.1 10.8 56.4 11.9 61.6 10.2 55.5 12.5 63.4 11.5 2.333 0.056 
Total SF– 36 domains 61.8 13.2 61.1 12.8 67.7 11.8 58.9 16.1 65.2 13.8 1.775 0.134 
According to table (4.25) at general, there are no statistical differences between Total SF-
36 domains and governorates (F=1.775, Sig. =0.134) as indicted by ANOVA test , but 
there are statistical differences between " Energy / Fatigue, Pain and governorates the 
differences was for the participant who lives in Rafah with mean 58.5 and 80.4 
respectively.  
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Mid zone governorate elicited the higher level of QOL (67.7), While Gaza governorate 
elicited the lowest level of QOL (61.1). Here, our study can't clarify why the QOL of 
patients in the mid-zone is better compared to other governorates, but this may be 
attributed to the small sample size that equal (7.5%). 
4.6.5.2 Differences in perceptions about QOL(GQL-15) according to address 
Results in table (4.26), shows the differences in the overall perceptions of QOL per 
address. Results showed that Glaucoma patients who live in Mid-zone have had slightly 
higher scores in all QOL domains (Central vision, Peripheral vision, Glare and dark 
adaptation), except (outdoor mobility), and had better in total GQL-15 scores than other 
Governorates. 
Table (4.26) Differences in perceptions about QOL(GQL-15) address 
 North Gaza Mid-zone Khanunis Rafah 
F Sig. 
Mean SD Mean SD Mean SD Mean SD Mean SD 
Central vision  
58.2 17.9 54.0 19.7 69.7 23.3 61.8 15.4 55.5 12.0 3.628 0.007 
Peripheral 
vision  
63.3 20.7 59.9 19.2 66.0 19.7 61.5 18.8 62.7 19.5 0.609 0.657 
Outdoor 
mobility  
69.0 25.0 64.1 24.2 68.8 29.1 70.7 26.8 67.7 29.0 0.766 0.548 
Glare and dark 
adaptation 48.4 17.8 46.5 17.9 57.5 16.3 50.3 18.7 49.8 17.3 1.835 0.122 
Total GQL-15 
domain 
59.8 17.9 56.8 17.4 66.0 20.4 63.5 15.8 59.5 17.8 1.835 0.123 
According to table (4.26) at general, there are no statistical differences between Total 
GQL-15 domains and governorates (F=-1.835, Sig.=0.123) as indicated by ANOVA test.  
Here, the researcher can't clarify why the QOL of patients in the mid-zone is better 
compared to other governorates, but this may be due to the small sample size that equal 
(7.5%). 
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4.6.6 QOL and Place services 
4.6.6.1 Differences in perceptions about QOL (SF – 36) according to Place services  
Table (4.27) shows the differences in the overall perceptions of QOL per Place services. 
Results presented that, Glaucoma patients receive service in EGH have better scores of the 
following QOL domains (Physical Function, Role limitation due to physical Health, Role 
limitation due to emotional problems, Social Functioning, General Health) and on both 
summary scales PCS and MCS, and total SF-36 scores than other patients in NOH. 
Table (4.27) Differences in perceptions about QOL (SF – 36) according to Place 
services 
 NOH EGH 
t test Sig. 
Mean SD Mean SD 
Physical Function 69.5 23.7 72.3 23.6 -0.905 0.366 
Role limitation due to physical 
Health 
52.2 28.4 63.2 23.7 -3.104 0.002 
Role limitation due to emotional 
problems  
55.2 32.0 64.7 31.9 -2.266 0.024 
Energy / Fatigue  54.7 9.2 52.8 11.5 1.488 0.138 
Emotional well being 55.0 12.4 54.0 14.7 0.576 0.565 
Social Functioning 70.8 28.8 75.2 28.6 -1.140 0.255 
Pain 80.9 31.5 76.3 37.0 1.048 0.296 
General Health 48.6 8.3 48.7 9.6 -0.080 0.937 
MCS 65.5 17.7 67.5 19.9 -0.851 0.395 
PCS 56.2 12.0 59.2 11.1 -1.945 0.053 
Total SF– 36 domains 60.9 13.1 63.4 14.3 -1.421 0.156 
According to table (4.27) t-test indicate that there are no statistical differences between 
Total SF-36 domains and place of services (t=-1.421, Sig. =0.156) as indicated by 
ANOVA test, but there are statistical differences between " Role limitation due to physical 
Health, Role limitation due to emotional problems and place of services the differences 
was for EGH. 
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4.6.6.2 Differences in perceptions about QOL(GQL-15) according to Place services 
Result in table (4.28), showed that glaucoma patients receive service in EGH have better 
scores in all QOL domains (Central vision, Peripheral vision, Outdoor mobility, Glare and 
dark adaptation), and total GQOL-15 scores. 
Table (4.28) Differences in perceptions about QOL(GQL-15) Place services 
 NOH EGH 
t test Sig. 
Mean SD Mean SD 
Central vision  55.8 19.6 60.4 17.7 -1.766 0.079 
Peripheral vision  61.2 19.7 62.0 18.8 -0.324 0.746 
Outdoor mobility  64.6 25.3 70.9 25.3 -1.891 0.060 
Glare and dark adaptation 47.4 18.0 50.7 17.8 -1.378 0.169 
Total GQL– 15 domains 58.1 17.7 61.7 17.4 -1.516 0.131 
According to table (4.28) t-test indicate that there are no statistical differences between 
Total GQL-15 domains and place of services (t=-1.516, Sig=0.131).  
Our study can't clarify why the QOL of patients EGH is better compared to NOH, but this 
may be attributed to the small sample size from EGH. Other Possible explanation that 
NOH is the main service provider for Glaucoma in the Gaza Strip, so a lot of cases of 
glaucoma are converted to it, especially in the latter stages of the disease who's have low 
QOL that‘s will have affected on the Total score of QOL for NOH.  
4.6.7 QOL and employment 
4.6.7.1 Differences in perceptions about QOL (SF – 36) according to employment 
The study finding as listed in Table (4.29) indicated that, glaucoma patients who work 
have higher scores in the domains of physical function, social function and mental health, 
Pain and on PCS summary, and total SF-36 scores than the patients who do not work. 
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Table (4.29) Differences in perceptions about QOL (SF – 36) according to 
employment 
 Yes No 
t test Sig. 
Mean SD Mean SD 
Physical Function 77.3 18.6 67.9 24.8 2.883 0.004 
Role limitation due to physical 
Health 
55.4 26.2 55.9 27.9 -0.141 0.888 
Role limitation due to emotional 
problems  
54.3 31.2 59.7 32.5 -1.199 0.232 
Energy / Fatigue  53.6 9.0 54.3 10.4 -0.439 0.661 
Emotional wellbeing 50.7 10.7 56.1 13.7 -3.025 0.003 
Social Functioning 73.0 23.8 71.9 30.4 0.277 0.782 
Pain 84.9 30.1 77.5 34.3 1.597 0.111 
General Health 47.9 8.0 48.8 9.0 -0.734 0.464 
MCS 65.7 16.3 66.3 19.1 -0.226 0.821 
PCS 58.6 9.9 56.7 12.3 1.121 0.263 
Total SF– 36 domains 62.1 10.8 61.5 14.4 0.332 0.740 
According to table (4.29) t-test indicate that there are no statistical differences between 
Total SF-36 domains and working (t=0.332, Sig. =0.740), but there are statistical 
differences between " Physical Function, Emotional wellbeing and working the differences 
was for the participant who is working in physical function with mean 77.3 while it's for a 
participant who didn't work in emotional wellbeing with mean 56.1. 
Our study clarifying why the QOL of patient's work is better compared to patient's not 
work, due to a patient who is working has better economic status, and having well 
communication, have better availability to different services and drug. Otherwise, QOL 
among patients who do not work was lower than that in those who work. Due to financial 
requirement, lack of resources, and insufficient basic needs that will affected negatively on 
QOL. For men, the best QOL was associated with high socioeconomic conditions and 
good physical and psychosocial health (Campos et al. 2014) 
4.6.7.2 Differences in perceptions about QOL(GQL-15) according to employment 
The study finding as listed in Table (4.30) indicated that glaucoma patients who is work 
have slightly better scores in the following QOL domains (Peripheral vision, Outdoor 
mobility, Glare and dark adaptation), and total GQL-15 scores. 
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Table (4.30) Differences in perceptions about QOL(GQL-15) employment 
 Yes No 
t test Sig. 
Mean SD Mean SD 
Central vision  55.9 20.3 57.8 18.7 -0.715 0.475 
Peripheral vision  63.8 16.6 60.6 20.3 1.159 0.248 
Outdoor mobility  68.2 20.8 66.0 26.9 0.617 0.538 
Glare and dark adaptation 49.9 19.7 48.0 17.3 0.762 0.447 
Total GQL– 15 domains 59.4 16.7 58.1 18.1 0.112 0.911 
According to table (4.30) t-test indicate that there are no statistical differences between 
Total GQL-15 domains and work (t=0.112, Sig=0.911).  
Most patients with glaucoma (73.6%) not work. This could be from the mean ages of 
glaucoma patient were higher or could suggest that the burden of living with glaucoma 
may have forced patients into retirement and not work. 
4.6.8 QOL and income 
4.6.8.1 Differences in perceptions about QOL (SF – 36) according to income 
The study finding as listed in Table (4.31) indicated positive association between income 
and QOL. Patients whose income was less than 1000 NIS were less QOL score 
(mean=59.4), and those with higher income were better QOL (mean=77.4)   
Results also that, glaucoma patients who have an income more than 2000 NIS, have better 
means of all QOL domains: physical functioning, physical role, general health, vitality, 
mental health, social functioning, pain, and emotional role, and on both summary scales 
PCS and MCS and total SF-36 scores compared to patients who have an income of less 
than 2000 NIS. 
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Table (4.31) Differences in perceptions about QOL (SF – 36) according to income 
 Less than 1000 1000 to 2000 Above 2000 
F test Sig. 
Mean SD Mean SD Mean SD 
Physical Function 66.0 24.9 76.0 16.3 92.8 8.5 16.859 0.000 
Role limitation due to 
physical Health 
54.1 25.5 52.3 31.9 77.2 22.5 8.217 0.000 
Role limitation due to 
emotional problems  
55.1 30.9 58.0 33.1 84.1 29.9 8.761 0.000 
Energy / Fatigue  53.4 10.1 55.4 10.2 57.2 8.2 2.060 0.130 
Emotional wellbeing 54.7 12.9 52.4 12.9 60.2 14.3 2.882 0.058 
Social Functioning 68.4 29.8 75.2 24.8 96.7 10.8 11.149 0.000 
Pain 75.3 35.2 86.5 28.7 96.6 16.2 5.942 0.003 
General Health 48.0 8.3 49.3 8.8 51.5 10.9 1.859 0.158 
MCS 63.4 18.3 68.0 16.4 84.4 11.9 15.267 0.000 
PCS 55.4 11.4 58.2 11.5 69.7 6.6 17.329 0.000 
Total SF– 36 domains 59.4 13.4 63.1 11.4 77.0 7.4 20.494 0.000 
According to table (4.31) ANOVA test indicate that there are statistical differences 
between Total SF-36 domains and income (F=20.494, Sig. =0.000), the differences was for 
the participant who had income above 2000 NIC with mean 77.0 while there are no 
statistical differences between Energy/ Fatigue, general Health and income.  
A result of our study consistent with Jain et al. (2015) that‘s conduct study to assess quality 
of life of glaucoma patients per WHOQOL-Brief reported that QOL of patients with high 
income was better, and Poor quality of life in all four domains was found to associate with 
lower income. 
4.6.8.2 Differences in perceptions about QOL(GQL-15) according to income 
The study finding as listed in Table (4.32) indicated positive association between income 
and QOL. Result also showed glaucoma patients who have an income more than 2000 NIS, 
have better means of all QOL (Central vision, Peripheral vision, Outdoor mobility, Glare 
and dark adaptation), and total GQL-15 scores (mean =85.3). 
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Table (4.32) Differences in perceptions about QOL(GQL-15) according to income 
 Less than 
1000 
1000 to 2000 Above 2000 
F test Sig. 
Mean SD Mean SD Mean SD 
Central vision  54.7 16.8 53.2 17.4 85.3 16.7 35.106 0.000 
Peripheral vision  58.2 17.7 60.5 17.4 89.9 13.8 34.112 0.000 
Outdoor mobility  63.8 25.5 65.3 21.9 92.4 17.6 14.335 0.000 
Glare and dark 
adaptation 
45.9 15.9 45.8 16.4 75.7 14.8 36.747 0.000 
Total GQL–15 domains 
55.9 15.2 59.0 13.5 85.3 18.5 34.122 0.000 
According to table (4.32) ANOVA test indicate that there are statistical differences 
between Total GQOL-15 domains and income (F=34.122, Sig.=0.000), the differences was 
for the participant who had income above 2000 NIC with mean 85.3. 
Our study clarifying why the QOL of patients with high income more than 2000NIS is 
better compared to other patients who is less than 2000 NIS due to have better 
socioeconomic status, have a purchasing power that enables it to buy all the medicines 
despite the high price tag and can make the necessary surgical procedures that maintain the 
stability of his health, have better availability to different services. 
Also, they can provide all the basic needs and even entertainment and that make them live 
in a state of stability and satisfaction. 
Our findings consistent with Zuo et al. (2015) conducted study to assess Vision health-
related quality of life in Chinese by GQL-15 among glaucoma patients reported that 
VRQOL of high income glaucoma patients was better than patients of low income in all 
four domains. 
4.6.9 QOL and other eye diseases 
4.6.9.1 Differences in perceptions about QOL (SF – 36) according to other eye disease 
The study finding as listed in Table (4.33) illustrate that QOL and other eye disease 
positively association. Results also showed that, Glaucoma patients don't have another eye 
disease have better scores of the all QOL domains (Physical Function, Role limitation due 
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to physical Health, Role limitation due to emotional problems, Emotional wellbeing, Social 
Functioning, pain, Energy/ Fatigue, General Health) and on both summary scales PCS and 
MCS, and total SF-36 scores than patients have other eye disease. 
Table (4.33) Differences in perceptions about QOL (SF – 36) according to other eye 
disease 
 Yes No 
t test Sig. 
Mean SD Mean SD 
Physical Function 68.0 24.7 71.9 23.0 -1.326 0.186 
Role limitation due to physical 
Health 
49.0 29.1 60.0 25.5 -3.244 0.001 
Role limitation due to emotional 
problems  
50.8 31.6 63.0 31.7 -3.043 0.003 
Energy / Fatigue  53.5 9.2 54.5 10.5 -0.776 0.438 
Emotional wellbeing 53.1 12.4 55.7 13.5 -1.560 0.120 
Social Functioning 68.0 29.7 74.9 27.9 -1.930 0.055 
Pain 78.4 32.0 80.1 34.2 -0.386 0.700 
General Health 47.2 8.5 49.5 8.8 -2.100 0.037 
MCS 62.6 17.4 68.4 18.7 -2.543 0.012 
PCS 54.4 12.1 59.0 11.2 -3.127 0.002 
Total SF– 36 domains 58.5 12.9 63.7 13.5 -3.094 0.002 
According to table (4.33) t-test indicate that there are statistical differences between Total 
SF-36 domains and Suffering from other eye diseases (t=-3.094, Sig. =0.002), the 
differences was for the participant who did not Suffering from other eye diseases with 
mean 63.7, while there are no statistical differences between Physical Function, Energy / 
Fatigue, Emotional wellbeing, Pain and Suffering from another eye diseases. 
Visual impairment due to ocular diseases has a negative impact on physical and mental 
health and is a global interest. In the USA, visual disability ranks among the top ten 
disabilities. (Courtney-Long et al. 2015). 
Decreased QOL was associated with the presence of glaucoma or corneal disease 
independent of visual acuity and with cataract or retinal disease as a function of visual 
acuity. (Nutheti et al. 2006). 
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4.6.9.2 Differences in perceptions about QOL(GQL-15) according to other eye disease 
The study finding as listed in Table (4.34) illustrate that QOL and other eye disease 
positively association. Results also showed that, Glaucoma patients don't have another eye 
disease have better scores of the all QOL domains (Peripheral vision, Central vision, 
Outdoor mobility, Glare and dark adaptation), and total GQOL-15 scores (mean = 62.0). 
Table (4.34) Differences in perceptions about QOL(GQL-15) according to other eye 
disease 
 Yes No 
t test Sig. 
Mean SD Mean SD 
Central vision  53.4 17.0 59.8 20.1 -2.587 0.010 
Peripheral vision  56.9 19.9 64.4 18.6 -3.106 0.002 
Outdoor mobility  61.7 25.2 69.8 25.1 -2.555 0.011 
Glare and dark adaptation 44.1 17.5 51.2 17.8 -3.187 0.002 
Total GQOL– 15 domains 55.0 16.5 62.0 17.9 -3.077 0.002 
 
According to table (4.34) t-test indicate that there are statistical differences between Total 
GQOL-15 domains and Suffering from other eye diseases (t=-3.077, Sig.=0.002), the 
differences were for the participant who did not Suffer from other eye diseases with mean 
62.0. 
Cataract influences glaucoma-related QOL among glaucoma patients of all severity levels 
and is an important cause of potentially reversible visual impairment among glaucoma 
patients (Skalicky et al. 2015). Sung et al. (2017) conduct study to evaluate vision-related 
quality of life in Korean glaucoma patients and to explore the associated factors reported 
that the lower (NEI VFQ-25) Rasch score showed a significant association in the presence 
of other ocular diseases.  
Patients treated for primary open-angle glaucoma or ocular hypertension often have ocular 
surface diseases, more often and more severely in older patients getting more drugs and 
presenting with more severe glaucoma. These high prevalence values might therefore have 
consequences on the burden of the disease in terms of adherence to treatment and quality 
of life (Baudouin et al. 2012). 
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Fechtner et al. (2010) conduct a study to determine the prevalence of ocular surface 
disease (OSD) in patients with glaucoma using topical intraocular pressure (IOP)-lowering 
therapy and reported OSD is prevalent among medically treated patients with glaucoma. 
The severity of OSD symptoms is positively correlated to the number of IOP-lowering 
medications used. As many as six in every ten patients with glaucoma have ocular surface 
disease, and this can have a huge impact on their daily lives. 
OSD adversely affects patients' quality of life causing discomfort and problems with vision 
which in turn may result in noncompliance, lack of adherence, and eventually visual 
impairment (Kaštelan et al. 2010).OSD has an estimated prevalence of 15% among 
individuals older than 65 years and this rises to 59% in patients with glaucoma. (Leung et 
al. 2008). 
Patients with topically treated glaucoma present dry eye syndrome more often than a 
similar control group. The presence of dry eye syndrome negatively influences the patient's 
QOL (Rossi et al. 2008). 
Moreover, Skalicky et al. (2012) reported that OSD was more common in patients with 
increasing glaucoma severity and is associated with poorer glaucoma-related QOL. 
4.6.10 QOL and comorbidities 
4.6.10.1 Differences in perceptions about QOL (SF – 36) according to comorbidities 
The study findings as listed in Table (4.35) indicated positive association between 
comorbidities and QOL. Results also showed that glaucoma patients who reported having a 
chronic disease were worse off than those who did not. 
Results also showed that, glaucoma patients not have chronic disease have better scores of 
the all QOL domains (Physical Function, Role limitation due to physical Health, Role 
limitation due to emotional problems, Social Functioning, pain, Energy/ Fatigue, General 
Health) and on both summary scales PCS and MCS, and total SF-36 scores than patients 
have a history of chronic disease. 
  
 97 
Table (4.35) Differences in perceptions about QOL (SF – 36) according to 
comorbidities 
 Yes No 
t test Sig. 
Mean SD Mean SD 
Physical Function 65.8 26.1 75.9 19.1 -3.510 0.001 
Role limitation due to physical Health 53.1 27.6 59.0 26.9 -1.739 0.083 
Role limitation due to emotional 
problems  
56.3 33.5 60.6 30.6 -1.066 0.287 
Energy / Fatigue  53.7 10.5 54.5 9.5 -0.661 0.509 
Emotional well being 55.0 13.3 54.4 13.0 0.377 0.706 
Social Functioning 67.7 31.6 77.7 23.9 -2.866 0.004 
Pain 71.3 37.6 89.2 24.1 -4.517 0.000 
General Health 47.1 8.5 50.4 8.7 -3.091 0.002 
MCS 62.6 20.2 70.5 14.8 -3.559 0.000 
PCS 54.9 12.4 59.9 10.3 -3.519 0.001 
Total SF– 36 domains 58.8 14.6 65.2 11.2 -3.968 0.000 
According to table (4.35) at general, there are statistical differences between Total SF-36 
domains and Suffering from Chronic diseases (t=-3.968, Sig.=0.000) as indicted by t-test , 
the differences were for the participant who didn't Suffer from Chronic diseases with mean 
65.2, while there are no statistical differences between Role limitation due to physical 
Health, Role limitation due to emotional problems, Emotional wellbeing, Energy / Fatigue, 
Emotional wellbeing and Suffering from Chronic diseases.  
DM-hypertension comorbidity and cardiovascular diseases had the most negative effect on 
the QOL scores in the physical domain. Mental disorders had the worst effect on the 
psychological and social relationships domains, and respiratory diseases had the worst 
effect on the environmental domain (Tüzün et al. 2015). In contrast, chronic diseases can 
be related to increased depressive symptoms, and the depression associated chronic 
diseases can negatively affect QOL (Bayliss et al. 2012). 
4.6.10.2 Differences in perceptions about QOL(GQL-15) according to comorbidities  
Findings and statistical analysis as Table (4.36) indicate that glaucoma patients not have a 
chronic disease have better scores in all QOL domains (Peripheral vision, Central vision, 
Outdoor mobility, Glare and dark adaptation), and total GQL-15 scores. 
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Table (4.36) Differences in perceptions about QOL(GQL-15) according to 
comorbidities 
 Yes No 
t test Sig. 
Mean SD Mean SD 
Central vision  56.0 18.6 58.7 19.7 -1.096 0.274 
Peripheral vision  58.8 19.5 64.6 18.9 -2.443 0.015 
Outdoor mobility  64.3 26.1 69.4 24.4 -1.619 0.107 
Glare and dark adaptation 46.9 17.1 50.3 18.9 -1.546 0.123 
Total GQL– 15 domains 57.6 17.0 61.1 18.2 -1.576 0.116 
According to table (4.36) at general, there are no statistical differences between total 
GQOL-15 domains and Suffering from Chronic diseases (t=-1.576, Sig.=0.116). 
Lin et al. (2010) conduct a study to Comparison of comorbid conditions between open-
angle glaucoma patients and a control cohort: a case-control study reported that Open-
angle glaucoma patients were significantly more likely to have comorbidities, many of 
which can be life threatening or can affect the quality of life significantly. 
Other chronic conditions also produce problems in pain and discomfort or daily activities, 
but differ from visual impairment in which activity they impede. Therefore, visually 
impaired patients with other chronic conditions maybe have more problems in a greater 
number of daily activities. Patients who are only visually impaired have also less pain or 
discomfort than those with comorbid conditions. 
A result from our study consistent with Zuo et al. (2015) conducted a study to assess 
Vision health-related quality of life in Chinese by GQL-15 among glaucoma patients 
reported that VRQOL of glaucoma patients with comorbid had worse than patients of 
without comorbid.  
Significant factors regarding impact on the quality of life were found concerning the 
complications to glaucoma, with an impaired visual acuity and visual field, and concerning 
the co-morbidity, especially concerning general diseases, both vascular and non-vascular 
(Wändell et al. 1997). 
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4.6.11 QOL and Duration of the disease 
4.6.11.1 Differences in perceptions about QOL (SF – 36) according to Duration of the 
disease 
The study finding as listed in Table (4.37) illustrate that, glaucoma patients have disease 
duration less than 5 years have slightly better scores of the all QOL domains (Physical 
Function, Role limitation due to physical Health, General Health) and on PCS summary 
scale, and total SF-36 scores. 
Table (4.37) Differences in perceptions about QOL (SF – 36) according to Duration of 
the disease 
 Less than 5 
Yrs. 
5 to 10 Yrs. Above 10 Yrs. 
F test Sig. 
Mean SD Mean SD Mean SD 
Physical Function 75.5 21.0 65.2 25.7 66.8 24.4 5.533 0.004 
Role limitation due to 
physical Health 
57.6 25.9 55.6 25.8 52.8 31.3 0.696 0.500 
Role limitation due to 
emotional problems  
57.1 31.6 57.3 32.5 61.1 33.1 0.393 0.676 
Energy / Fatigue  53.5 10.5 54.2 8.9 55.1 10.3 0.567 0.568 
Emotional well being 55.2 13.7 52.9 11.6 55.7 13.6 0.940 0.392 
Social Functioning 75.1 28.1 64.3 30.2 75.2 27.2 3.789 0.024 
Pain 77.5 35.4 78.3 30.6 83.8 32.4 0.875 0.418 
General Health 49.1 8.7 47.8 8.7 48.5 8.8 0.580 0.561 
MCS 66.2 18.3 63.2 18.8 68.9 17.9 1.771 0.172 
PCS 58.9 11.2 55.7 10.8 55.8 13.2 2.453 0.088 
Total SF– 36 domains 62.6 12.7 59.4 13.9 62.4 14.4 1.338 0.264 
According to table (4.37) at general, there is are  statistical differences between Total SF-
36 domains and duration of the disease (F=1.338, Sig.= 0.264) as indicated by ANOVA 
test, but there are statistical differences between " Physical Function, Social Functioning 
and Duration of the disease the differences was for the participant who has  disease 
duration  from 5 years and less in physical function with mean 75.5 while it's for a 
participant who has disease duration  above 10 years in Social Functioning with mean 75.2. 
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Our study explained that the mean score of some QOL domain among older patients was 
higher than among younger age; the reason is: the elderly may have adapted with the 
disease and with the truth in which they live, Moreover, positive religious dimension leads 
also to general satisfaction with health condition. 
Janz et al. (2007) conduct a study to assess fear of blindness in glaucoma patients over 
time and reported that the most significant correlate over time was the perceived impact of 
the disease on an individual‘s ability to perform visual tasks. They noted a reduction from 
34% of patients who were afraid of going blind at the onset to 11–12% after 5 years. They 
attached this reduction to faith, more knowledge about the low risk of blindness with 
treatment and adaptation to the diagnosis. 
4.6.11.2 Differences in perceptions about QOL(GQL-15) according to Duration of the 
disease 
The study finding as listed in Table (4.38) illustrate that QOL and duration of disease 
positively association. Results also showed that, glaucoma patients have a duration of 
disease (less than 5 years) have better scores in all QOL domains (Peripheral vision, 
Central vision, Outdoor mobility, Glare and dark adaptation), and total GQL-15 scores 
than patients have duration more than 5 years. 
Table (4.38) Differences in perceptions about QOL(GQL-15) according to Duration 
of the disease 
 Less than 5 
Yrs. 
5 to 10 Yrs. Above 10 Yrs. 
F test Sig. 
Mean SD Mean SD Mean SD 
Central vision  63.0 18.3 53.3 18.5 51.0 18.4 10.947 0.000 
Peripheral vision  69.5 17.6 59.7 22.0 49.5 11.4 29.983 0.000 
Outdoor mobility  79.1 19.9 65.9 29.0 46.2 14.3 52.927 0.000 
Glare and dark 
adaptation 
53.0 18.6 46.5 20.6 42.8 10.9 8.381 0.000 
Total GQOL– 15 
domains 
66.8 16.0 56.8 19.7 48.1 10.2 29.651 0.000 
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According to table 4.39 at general, there are statistical differences between Total GQOL-15 
domains and treatment period (F=29.651, Sig. =0.000) as indicated by ANOVA test, the 
differences was for the participant who was treated from 5 years with mean 66.8. 
A trend of deterioration QOL score was noted from this study and suggests that QOL 
deteriorates with progression of disease. This result consistent with. (Janz et al., 2001; 
Nelson et al., 2003; Parrish 1996; Skalicky & Goldberg 2008; Goldberg et al., 2009). 
Floriani et al., (2015) conduct study to assess Health‐related quality of life in patients with 
primary open‐angle glaucoma reported that QOL decreased with advancing disease 
severity. Visual field loss in progressing glaucoma is independently associated with a loss 
in both disease-specific and generic quality-of-life (van Gestel et al., 2010). 
Our study explained the worse in the VRQOL with increasing the duration due to the 
disease is progressive over time and the lack of follow-up, adherence to treatment also 
health problems that associated with elderly, which worsens the QOL level. 
Result consistent with Zuo et al. (2015) conducted a study to assess Vision health-related 
quality of life in Chinese among glaucoma patients reported that VRQOL of glaucoma 
patients had worse with increasing the duration of disease. 
4.6.12 QOL and compliance with treatment 
4.6.12.1 Differences in perceptions about QOL (SF – 36) according to compliance 
with treatment 
The study finding as listed in Table (4.39) illustrate that, compliance glaucoma patients 
with treatment have slightly better scores of the all QOL domains (Physical Function, Role 
limitation due to physical Health, General Health) and on PCS summary scale, and total 
SF-36 scores. 
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Table (4.39): Differences in perceptions about QOL (SF – 36) according to 
compliance with treatment 
 Yes No 
t test Sig. 
Mean SD Mean SD 
Physical Function 70.8 23.4 58.3 29.2 1.556 0.121 
Role limitation due to physical 
Health 
56.1 27.5 47.2 23.2 0.951 0.343 
Role limitation due to emotional 
problems  
57.9 32.2 66.7 33.3 -0.799 0.425 
Energy / Fatigue  54.5 9.6 42.2 14.8 3.704 0.000 
Emotional wellbeing 54.4 13.1 62.7 13.7 -1.858 0.064 
Social Functioning 72.4 29.1 68.1 18.9 0.441 0.660 
Pain 79.8 33.2 69.2 37.1 0.938 0.349 
General Health 48.7 8.8 46.7 5.6 0.671 0.503 
MCS 66.1 18.3 66.6 21.6 -0.082 0.935 
PCS 57.5 11.6 48.6 13.4 2.248 0.025 
Total SF– 36 domains 61.8 13.5 57.6 15.4 0.913 0.362 
According to table (4.39) at general, there are no statistical differences between Total SF-
36 domains and compliance with treatment (t=1.681, Sig.=0.362) as indicated by t-test, but 
there are statistical differences between " Energy / Fatigue and Adherence to treatment the 
differences was for the participant who compliance with treatment with mean 54.5. 
4.6.12.2 Differences in perceptions about QOL(GQL-15) according to compliance 
with treatment  
The study finding as listed in Table (4.40) illustrate that, glaucoma patients who 
compliance with treatment had better scores in three from four QOL domains (Peripheral 
vision, Outdoor mobility, Glare and dark adaptation), and total GQOL-15 scores than 
patient's who not compliance with treatment. 
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Table (4.40) Differences in perceptions about QOL(GQL-15) according compliance 
with treatment 
 Yes No 
F test Sig. 
Mean SD Mean SD 
Central vision  57.0 19.5 58.1 19.4 -0.696 0.487 
Peripheral vision  61.6 19.6 56.0 13.0 0.853 0.394 
Outdoor mobility  67.0 25.4 55.6 24.3 1.328 0.185 
Glare and dark 
adaptation 
48.7 18.1 42.6 11.7 0.998 0.319 
Total GQL– 15 domains 59.1 17.8 54.5 8.3 -0.226 0.822 
According to table (4.40) at general, there is no statistical differences between Total GQL-
15 domains and compliance with treatment (t=-0.226, Sig.=0.822) as indicated by t-test. 
The full-adherence rate is low among glaucoma patients. Having less belief in the need for 
and more concerns about their medication are the 2 factors associated with nonadherence 
(Loon et al., 2015) 
Glaucoma patients are more likely to be adherent to their medication if they understand the 
disease and the rationale for treatment and if their treatment regimen is simplified (Robin 
et al., 2011). 
Rotchford et al., (1998) conduct study to assess compliance with timolol treatment in 
glaucoma reported that compliance with treatment is poor and patients underestimate their 
level of defaulting when questioned. 
A patient‘s perception, belief system and experiences may also affect his/her QOL. 
This fear of blindness can have several effects on the patient‘s attitude. It may create a 
healthy care that makes the patient extremely compliant and adherent to drug usage and 
follow-up visits, which is useful. or it could make the patient, hopeless and uninterested in 
whatever therapy is being offered to them with following poor drug compliance and 
irregular attendance at clinic visits. 
Our study explained that the compliance patients have better QOL than not compliance due 
to treatment is directed at reducing eye pressure to prevent optic nerve damage and loss of 
vision. And treatment in glaucoma is to improve clinical outcome by preventing further 
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progression of the disease and in the end, preserve or improve the patients QOL. 
Therefore, patients must adherence to treatment. 
Possible explains for not compliance, that glaucoma is a chronic disease often requiring 
many years of treatment, which can be inconvenient and expensive. And many patients 
simply "forget" to take their medication, and many glaucoma medications have side effects 
that range from unpleasant to disabling. 
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Chapter (5) Conclusion and Recommendations 
This chapter provides the main conclusion and the recommendations for the key persons 
and decision makers in MOH to focus on improving the Glaucoma patient's life that 
increase QOL for those patients. 
5.1 Conclusion 
Glaucoma represents a most important threat for millions of people around the world, 
including Palestine. Glaucoma disease in GS is considered one of the exhausting diseases. 
Glaucoma patients suffer from two aspects; the chronic nature of the disease itself in terms 
of regular hospital visits, drug availability, side effects of drugs and disease complications, 
and the implications of the disease on the quality of life of a patient. 
Dimensions of QOL among Glaucoma patients relatively are reduced, per that reduction; 
improvement of life's dimensions is the key of achieving better coping with that disease. 
This study has proven that glaucoma has broad effects on people‘s ability to function 
independently in every field of their lives. It affects the physical, mental and social well-
being of people. 
Early detection and aggressive treatment of early glaucoma should be improved to prevent 
progression of the disease and decrease in QOL. 
The conduction of this study is to discover what is important for understanding how 
glaucoma disease affects the QOL of patients, and reduced QOL domains. Glaucoma can 
affect the ability of patients to perform activities of daily living and personal care and can 
cause poor learning and mobility. All these at last lead to loss of self-confidence and 
independence. 
This study has used a quantitative measure that providing an important assessment of the 
QOL among Glaucoma patients in GS. It also gives powerful and multidimensional 
concepts about QOL among Glaucoma patients. Additionally, it provides a detailed and 
widespread understanding of how the disease affects the QOL of patients.  
This study has been conducted to assess the QOL among patients with Glaucoma disease 
who live in GS to improve the patients' life that may positively affect the health status. The 
study explores the eight SF-36 domains and four GQOL-15 domains. It also explores the 
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differences in perceptions of Glaucoma patients for QOL about demographics, 
socioeconomic and health profile variables. 
Regardless of suffering from Glaucoma disease, the response rate was high and the total 
SF-36 mean score was 61.7 (SD=13.5), meaning that most of the respondents had a 
medium perception level of QOL. The overall mean percentage of SF-36 domain scores 
ranged from (48.58%) to (79.4%). 
The bodily pain domain got the highest score with equaled (79.4%). Moreover, the social 
function domain was (72.22%), the physical function domain (70.32%), the emotional role 
limitation (58.24%), the role limitation due to physical health (55.75), the mental health 
domain -Emotional wellbeing- (54.7%), the vitality domain (54.09%), and the lowest 
domain were General health with equaled (48.58%). 
Also, the total GQOL-15 mean score was 59.2 (SD=17.6), meaning that most of the 
respondents had a medium perception level of QOL and the overall mean percentage of 
GQOL-15 domain scores ranged from (48.5%) to (66.6%). 
The Outdoor mobility domain got the highest score with equaled (66.6%). Moreover, the 
Peripheral vision domain was (61.4%), the Central vision domain (57.3), and the lowest 
domain were Glare and dark adaptation with equaled (48.5%). 
The study results demonstrate a significant positive perception of Glaucoma patients, about 
their QOL. Moreover, most of them are satisfied with their health, which means that, 
religious dimension of GG community, social support system of GG and how the 
religiosity factor could influence QOL and subjective well-being and how patients in 
difficult conditions accept peacefully their fate. 
Significant differences were explored concerning demographic variables. Regarding the 
gender, there were statistically significant differences between Total SF-36 domains and 
Gender, the differences was in the domains "Physical Function, Role limitation due to 
emotional problems, Social Functioning and Pain" the differences was for male with means 
higher than females. In contrast, there were no statistical differences between Total 
GQOL– 15 domains and gender. 
Regarding the educational level, there were significantly differences between educated 
patients, particularly university level in comparison with illiterate and primary level 
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patients. Results show that glaucoma patients when attended more education represented 
higher QOL 
Regarding the age, there were no statistically significant differences between Total SF-36 
domains and Gender, but there are statistical differences between Physical Function and 
age group. The differences were toward the glaucoma patients with age (18-30) that have 
higher scores in the Physical Function domain than the other age group patients. On the 
other hand, there were no statistical differences between Total GQOL– 15 domains and age 
group. 
Concerning the marital status of patients, there were no statistically significant differences 
between Total SF-36 domains and Marital status. Moreover, there were no statistical 
differences between Total GQOL– 15 domains and marital status. 
There were no statistically significant differences between Total SF-36 domains and 
(Address, Place of service). Moreover, there were no statistical differences between Total 
GQOL– 15 domains and (Address, Place of service). 
According to the socioeconomic variables, Significant differences were explored. 
Regarding the employment, the study reported no statistically significant differences 
between Total SF-36 domains and working, but there are statistical differences between 
Physical Function, Emotional wellbeing and working for the participant who is working. 
This means that QOL is in favor of patients who work than patients who don't work. 
This could be explained as working patients have better economic status, and having well 
communication, have better availability to different services and drug. Then again, there 
were no statistical differences between Total GQOL– 15 domains and employment. 
For the income, there were statistically significant differences between Total SF-36 
domains and income, the differences were in all QOL domains (physical functioning, 
physical role, general health, vitality, mental health, social functioning, and emotional role 
domains). 
Furthermore, there were statistical differences between Total GQOL– 15 domains and 
income, the differences were in all QOL domains (Peripheral vision, Central vision, 
Outdoor mobility, Glare and dark adaptation). which means that patients with high income 
have a better degree of QOL domains. 
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Regarding to health profile variables, the study found that glaucoma patients without 
another ocular disease have a better score of all QOL domains in (SF-36 and GQOL-15). 
Moreover, the study found that glaucoma patients without comorbidities have     a better 
score of all QOL domains IN (SF-36 and GQOL-15). 
For the duration of the disease, there were no statistically significant differences between 
Total SF-36 domains and duration of the disease, but there are statistical differences 
between Physical Function, Social Functioning and duration of the disease, the differences 
were for the patients who have disease duration less than 5 years. On the other hand, there 
were statistical differences between Total GQOL– 15 domains and Duration of the disease, 
the differences were in all QOL domains (Peripheral vision, Central vision, Outdoor 
mobility, Glare and dark adaptation) for the patients who have disease duration less than 5 
years. Which means that patients with disease duration less than 5 years have a better 
degree of QOL domains. 
Regarding to compliance with treatment, there were no statistically significant differences 
between Total SF-36 domains and compliance with treatment. Moreover, there were no 
statistical differences between Total GQOL– 15 domains and compliance with treatment. 
5.2 Recommendations  
This study has provided useful information about QOL of patients with Glaucoma disease. 
Based on the findings and experiences gained throughout the study the following 
recommendation oriented to NOH and EGH management, followed by recommendation to 
MOH. 
Regarding NOH and EGH management, the following is recommended:  
 Routine constant QOL assessment is helpful to recognize individual areas of need, 
which can be addressed and establishing screening program among elderly people. 
and there should be a clear protocol on how to use the information obtained from 
QOL assessments.  
 Vision rehabilitation program  
 Provision of visual filed instrument in NOH.  
 Inclusion of contrast sensitivity, glare and dark adaptation assessment in routine 
clinical management of glaucoma patients. 
 119 
 Professional psychological support and low vision care should be provided for 
patients who need it to prevent mental health issues, behavioral problems and 
illness complications.  
 Development of medical patient file at diagnostic units, and enhance proper 
documentation specially at post care and follow up stages.  
 Supporting optometry care by designing and implementing educational programs 
for the optometrist to help them to provide optometry interventions to Glaucoma 
patients and counseling sessions, to be able to cope with the new condition. 
MOH is the main regulator of Palestinian health care system, so it has to be 
responsive to hospital needs through: 
 Achieving stability in the availability of fundamental medications. 
 Multisector coordination between MOH, Ministry of Labor and Ministry of Social 
Affairs to support, meet needs and provision of suitable treatment for patients that 
in turn comprehensively improves the disease burden and the QOL in glaucoma 
patients.  
 Empowering health information system at hospitals to enhance regular monitoring 
of hospitals performance, and improve registration system. 
 Increase the number of ophthalmology doctor with subspecialty in Glaucoma and 
Increase the number of Glaucoma units in both NOH and EGH. 
Encouragement for Future Research Studies 
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Annex (1): Map of Palestine 
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Annexes (2) QOL domains 
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Annexes (3) QOL Assessment Tools for Glaucoma 
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Annexes (4) Sample of the study 
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Annexes (5) SF-36 Questionnaire 
 
 133 
 
 
 
 
  431
 noisrev cibarA 63-FS
 غزة قطاع فٌ انجهوكويا يرضي نذى انحَاة جودة نخقََى اسخبَاٌ
 :انشخصَت أحوال
 :َفسك عٍ انعبيخ الأسئهخ ثعط ًهع الإجبثخ يُك َىد
 
 اَثً  □ركش            □      انجُس -1
 
 فأكثش  14□سُخ      14-13 □سُخ      13-81       □انعًر -2
    
  جبيعٍ     □انًشدهخ انثبَىَخ  □    انًشدهخ الأسبسُخ  □أي ٍّ   □        انذرجت انعهًَت -3
 
 غُش رنك  □يزضوج     □أعضة      □   انحانت الاجخًاعَت  -4
 
 سفخ □خبَُىَس      □     انىسطً  □غضح      □   انشًبل  □انًحافظت      -5
 
 يسزشفً الاوسوثٍ   □  يسزشفً انعُىٌ  □    يكاٌ حهقٌ انخذيت -6
 
 لا َعًم  □     َعًم           □  انعًم -7
 
 شُكم  1112أكثش يٍ  □ شُكم       1112-1111 □شُكم      1111اقم يٍ  □   انذخم انشهرً -8
 
 (يُز انىلادح) خهقُخ □  يغهق انضاوَخ  □يفزىح انضاوَخ    □    َوع يرض انجهوكويا -9
 
 لا  □َعى     □    هم اَج يصاب بأً يرض عَوٌ ّاخر -11
 
 لا  □  َعى         □    هم أَج يصاب بأً يرض يزيٍ -11
 
  فأكثشسُىاد  11 □سُىاد    11-5 □سُىاد     5أقم يٍ  □ يذة انًرض -21
 
 غُش يهزضو □قهُم الانزضاو    □يهزضو     □   يذى الانخزاو بانعلاج – 31
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Annexes (6) Scoring the SF-36 questionnaire  
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Annexes (7) SF-36 dimensions  
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Annexes (8) Glaucoma Quality of Life-15 Questionnaire 
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 noisrev -cibarA eriannoitseuQ 51-efiL fo ytilauQ amocualG
 لا 
 صعوباث
 صعوباث صعوباث قهَهت
 يخوسطت
انكثَر يٍ 
 انصعوباث
صعوباث 
 شذٍذة
 
لا ٍؤدٍها 
لأسباب لا 
 حخعهق بانُظر 
 0 5 4 3 2 1 قشاءح انصذف .1
انسُش ثعذ دهىل  .2
 انظلاو
 0 5 4 3 2 1
 0 5 4 3 2 1 انشؤَخ فٍ انهُم .3
انسُش عهً اسض  .4
 غُش يسزىَخ
 0 5 4 3 2 1
انزأقهى يع انضىء  .5
 انًشع
 0 5 4 3 2 1
انزأقهى يع انضىء  .6
 انخبفذ
 0 5 4 3 2 1
الاَزقبل يٍ غشفخ  .7
يضُئخ انً اخشي 
 يعزًخ او انعكس
 0 5 4 3 2 1
 0 5 4 3 2 1 انزعثش ثبلاجسبو .8
الاجسبو انقبديخ سؤَخ  .9
 يٍ انجبَت
 0 5 4 3 2 1
 0 5 4 3 2 1 عجىس انطشَق .11
 0 5 4 3 2 1 انسُش عهً انذسج .11
 0 5 4 3 2 1 الاسرطبو ثبلاجسبو .21
رقذَش انًسبفخ ثٍُ  .31
انقذو وانذسج او 
 دبفخ انشصُف
 0 5 4 3 2 1
اَجبد الاجسبو انزٍ  .41
 اوقعزهب
 0 5 4 3 2 1
 رًُُض انىجىِ .51
 
 0 5 4 3 2 1
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Annexes (9)   Academic approval 
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Annexes (10) Helsinki Committee approval 
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Annexes (11) MOH approval 
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 حقََى جودة انحَاة نذى يرضي انجهوكويا (انًَاِ انزرقاء) فٌ قطاع غزة
 عذاد: يذًذ صكشَب يشزهًإ
  ششاف: د أششف انجذٌإ
 يهخص انرسانت
 مقدمة
(زرق العين) ىو السبب الرئيسي الثاني لمعمي في العالم. وىو عبارة عن مجموعة من امراض العين التي الجموكوما 
تتمف الوظيفة البصرية بشكل دائم. والتي بدورىا تؤثر سمبا عمى جودة الحياة، وتعتبر جودة الحياة مؤشرا ىاما لتقييم 
زمنة. لذلك كان اليدف العام من الدراسة ىو تقييم جودة جودة الرعاية الصحية لممرضى الذين يعانون من الامراض الم
 الحياة لدى مرضى الجموكوما (زرق العين) في محافظات غزة.
 المنهجية
 265تصميم ىذه الدراسة وصفي تحميمي مقطعي لقياس جودة الحياة لدى مرضى الجموكوما. حيث استيدفت الدراسة 
فما فوق ويخضعون لمعلاج والمتابعة في مستشفى النصر  18 مريضا من مرضى الجموكوما والذين تبمغ أعمارىم
و  eriannoitseuQ 63-mroF trohSلمعيون ومستشفى غزة الأوروبي، وقد تم جمع البيانات من خلال الاستبيانات 
 %)6.11معدل استجابة ( مع 51-efil fo ytilauq amocualG
 النتائج
أظيرت النتائج ان جودة الحياة لدى مرضى الجموكوما في غزة كانت متوسطة، وبمغ متوسط الحرز الإجمالي لاستبيان 
واظير المرضى صعوبة كبيرة في الأنشطة المتعمقة بالتكيف مع الظلام  6..8±5..2ىو    51-LOQGجودة الحياة 
. وأيضا بمغ 6.66والاقل صعوبة ىو التنقل بالخارج  ،5.86، الرؤية المحيطية 5..2، تمييا الرؤية المركزية 2.15
وفق المقاييس الفرعية.  5...و 2.15متراوحا بين  ..86ىو  63-FSمتوسط الحرز الإجمالي لاستبيان جودة الحياة 
وحصل محور (النشاط الاجتماعي)  5...كما اشارت النتائج ان محور (الألم الجسدي) حصل عمى أفضل متوسط 
 .12.15نما كان أدني محور كان (الصحة العامة) ، بي55.5.عمى 
) حصمت عمى 35-18بينت النتائج أيضا ان مستوى جودة الحياة لدى الاناث أفضل من الذكور، وان الفئة العمرية (
اعمى مستوى جودة حياة مقارنة بالفئات العمرية الأخرى، كما أظيرت الدراسة ان مرضى الجموكوما ذوي الدخل الأعمى 
 شيكل يتمتعون بجودة حياة اعمى من ذوي الدخل المتدني. 3338من 
في حين أوضحت النتائج ان مرضى الجموكوما المصابين بمرض عيون اخر او مرض مزمن كانت ليم مستويات جودة 
 2الحياة اقل من غير المصابين بالإضافة أيضا فقد وجدت النتائج ان المرضى المصابين ب الجموكوما بمدة اقل من 
 ت كانت ليم مستويات جودة الحياة الأفضل.سنوا
وأخيرا كانت مستويات جودة الحياة لممرضى من حممة الشيادات الجامعية أفضل بكثير مقارنة بحممة الشيادات الثانوية 
 واقل. وايضا كان مستوى جودة الحياة أفضل بين المرضى الذين يعممون مقارنو بالعاطمين عن العمل.
 الخلاصة
الى ان جودة الحياة لدى مرضى الجموكوما في قطاع غزة كانت متوسطة، واظيرت الدراسة بعض  خمصت الدراسة
المشكلات المشتركة التي صادفت المرضى والتي لا تظير خلال الفحص الروتيني والدوري ليم. ويتضح من الدراسة 
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ممرضى. وأخيرا مرضى الجموكوما ان مرض الجموكوما يؤثر بشكل سمبي عمى الحالة الجسدية والاجتماعية والنفسية ل
 يجب تثقيفيم لفيم المرض وخطورتو ومدى أىمية الالتزام بالعلاج.
 التوصيات
 تسمط النتائج الضوء عمى بعض التوصيات الميمة منيا
 زيادة الجيود المبذولة لمنع تدني المستوى في جودة الحياة وما يترتب عميو من اثار سمبية عمى حياة المرضى  
 ية الأولية لمعيون من خلالدعم الرعا 
تنفيذ برامج تثقيفية للأطباء واخصائي البصريات لتقديم جمسات استشارية تساعد المرضى عمى التكيف  -
 مع حالتيم المرضية
 تنفيذ برامج إعادة التأىيل البصري لمرضى الجموكوما  -
 تطوير الممفات الطبية لممرضى 
 تحسين جودة الحياة ليم وتخفيف عبء المرض عنيمتوفير الدعم الاجتماعي والمالي لممرضى بيدف  
 توفير الادوية بشكل دائم لممرضى  
 تقديم برامج مناسبة تيدف الى تحسين الوضع النفسي لممرضى  
 زيادة عدد العيادات الطبية المتخصصة لعلاج مرضى المياه الزرقاء، لمكشف المبكر عن المرض. 
 
 
 
